Table Of Content

Epilepsia, 41(12):1649-1653, 2000 Lippincott Williams & Wilkins, Inc., Baltimore © International League Against Epilepsy Epilepsia Volume 41, 2000 Author Index Aberg LE, 1296 Beck H, 1249 Brodie MJ, 977 Abetz L, 1119 Beckerman B, 1269 Brodtkorb E, 529 Abou-Khalil B, 391 Beelke M, 201 Bromfield EB, 170 Abou-Khalil BW, 1187 Begemann M, 105 Brooks J, 98 Adamolekun B, 1044 Beghi E, 110 Brown MB, 1330 Adelson PD, 193 Begley CE, 342 Brown RJ, 1608 Aimi Y, 10 Behr J, 925 3rown S, 110 Airaksinen EM, 1214 Bell BD, 992 Bruce JN, 1463 Akata T, 909 Benardo LS, 1507 Buchhalter JR, 395 Al-Aweel IC, 536 Benbadis SR, 895 Buchheim K, 635 Aldenkamp AP, 1167 Ben-Menachem E, 1276 Buchner H, 71, 1574 Alenius M, 1289 Beran ME, 875 Buck D, 98 Alvarez LA, 1206 Beran RG, 875 Bulman DE, 132 Amarakone A, 1241 Berendschot TTJM, 581 Burgess DL, 24, 1074 Amark P, 308 Berg AT, 760, 1269 Burkhardt RT, 850 Andermann F, 113, 666, 825, 832 Bergin PS, 231 Burmeister M, 1046 Anhoury S, 1608 Burnham WM, 1400 Berkovic S, 529 Annegers JF, 342, 549 Burns L, 1540 Berkovic SF, 48, 463 Ansakorpi H, 42 Berlangieri SU, 463 Bussa B, 744 Antel SB, 832 Berry DJ, 624 Bye AME, 765, 1456 Anzivino MJ, 493 Berthele A, 818 Byun HS, 207 Arai N, 1489 Bertram E, 493 Armand V, 28 Bertram EH III, 502 Cairns DR, 765 Armitage LL, 1095 Besag FMC, 624 C alabrese G, 19 Arnold DL, 666, 825, 832 Bespalova IN, 1046 C amfield C, 1230 Arnold S, 818, 1153 Arpino C, 1436 Betts TA, 1420 C amfield P, 1230 Beyenburg S, 140 C ampbell BR, 332 Arrigo C, 868 Bialer M, 1107 C anizares S, 1303 Arroyo S, 1303 Bidlingmaier F, 140 C antello R, 694 Arunkumar G, 1474 Asconapé J, 479 Bielen E, 1179 C apurro D, 110 Bilir E, 963 C araballo R, 380 Ashizawa T, 24 Assal F, 687 BBiinndgearm aLnM , W,3 3297 1 ¢C aarrraamsacno osM arZi, na8 32,L L, 156170 05 Atzman O, 81 Binnie CD, 59, 1346 C ascino GD, 843 Austin JK, 615 Birbeck GL, 277 ( “assinello Garcia E, 1005 Avasthi G, 718 Avery RA, 1560 Birnbaum AK, 850 ¢ ‘astilla EE, 1436 Bjornes H, 91 C ‘avalli A, 694 Blanke O, 687 C “endes F, 666, 832 Babb T, 971 Bleasel A, 457 C “ereghino JJ, 868 Backman M, 1296 Bleasel AF, 765, 1456, 1540 C ‘espuglio R, 794 Baglietto MG, 201 Blom BH, 802 ¢ ‘hadwick D, 110, 1167 Bailet LL, 426 Blum AS, 536 C “*hadwick DW, 243 Baker G, 1167 Blum D, 1187 C ‘hang Y-C, 412 Baker GA, 98, 1119, 1357 Blum DE, 213 ( “hapouthier G, 651 Baker SA, 1616 Bliimcke I, 140, 1249 C ‘hen C, 1162 Bakker C, 19 Blustein JN, 895 C “hen Z-F, 493 Baldwin RA, 123 Boget T, 1303 C ‘heyette S, 862 Ball DE, 1044 Boleaga B, 158 C “hiarelli F, 1432 Balottin U, 1485 Bongiovanni LG, 1129 C “*hinvarun Y, 463 Barber C, 1420 Boon P, 440, 601 C “hung C-K, 1450 Barcs G, 1597 Borgatti R, 1485 ¢ ‘ian P, 222 Barnes PMF, 1420 Borowicz KK, 1112 C ‘ivardi C, 694 Barry JJ, 81 Bosco P, 19 C ‘lancy RR, 903 Bartenstein P, 818 Bouilleret V, 642 Clarke I, 48 Bartoli A, 222 Bourgeois BFD, 1057 Clayburn H, 502 Bast T, 1284 Bowling S, 963 Clear D, 243 Baudewig J, 71 Brans B, 601 Coan S, 342 Bauer J, 140 Brenner RP, 193 Coan SP, 549 Baumgartner C, 610, 1567 Brescianini S, 1436 Cocchi G, 1436 Baxendale SA, 231 Brigell MG, 148 Cohen JA, 148 Bazil CW, 760, 1463 Brito F, 158 Collins S, 1195 1650 AUTHOR INDEX Cook MJ, 1456, 1540 Ebner A, 564 Gonzalez-Hernandez T, 1259 Cooper P, 1167 Elger CE, 140, 186, 467, 811, 1249, 1597 Goodman RR, 1463 Corcoran ME, 1095 Elia M, 19 Greco R, 1432 Cornaggia CM, 110 Elices E, 1303 Greitz D, 290 Cornel MC, 1436 Elisevich K, 316, 1046 Gréppel G, 610 Corsi M, 1560 Elmquist J, 34 Gruenthal M, 240 Coughlin CT, 898 Emsley CL, 749 Grunze H, 1102 Cramer JA, 868 Ephraim T, 1522 Gudmundsson G, 1201 Crumrine PK, 193 Epilepsy Care Evaluation Group, 1014 Guénot M, 681 Cryer C, 1014 Erba G, 732 Giilgonen S, 405 Cunnane SC, 1400 Ergene E, 213 Gunter MJ, 1020 Czuczwar SJ, 1112, 1364 Eslinger PJ, 906 Guo N-W, 412 Eviatar L, 219 Guo Y-C, 1162 D’ Havé M, 601 Gupta AK, 718 D’Souza J, 1597 Fakhoury T, 391 Dahlin M, 308 Falter U, 1276 Haas-Lude K, 628 Dal Corso G, 967 Famulari M, 342 Hablitz JJ, 1082 Dammerman RS, 1080 Faradji H, 794 Hadam J, 971 Dani JA, 1063 Fattore C, 222 Halonen P, 1214 Data JL, 1187 Faught E, 963, 1342, 1546, 1626 Haltiner AM, 992 Davies KG, 992 Fazilat S$, 1227 Hamer HM, 554, 1039 De Boer H, 110 Fejerman N, 380 Handforth A, 1195 De Carli F, 201 Ferri R, 19 Hannesson DK, 1095 de Haan GJ, 1167 Ferrillo F, 201 Hara T, 1642 de LaCalle S, 34 Fiaschi A, 1129 Harding GPA, 1420 De Negri E, 201 Fiedler M, 516 Hardus P, 581 De Reuck J, 601 Fischer C, 681 Harnadek MCS, 1321 De Sarro GB, 19 Fish DR, 231 Hashimoto N, 1411 de Vasconcelos AP, 363 Fisher RS, 148 Haugvicova R, 1235, 1375 de Vigan C, 1436 Flesch G, 1597 Hauser A, 110 Dean P, 1206 Fodzo L, 432 Hauser WA, 549, 1201 Debilly G, 794 Foldvary N, 971 Hayakawa F, 714 Debus O, 588 Forgione M, 1463 Heck C, 1195 DeCarli C, 1227 Forsgren L, 1469 Heinemann U, 28, 635, 925 Deckers CLP, 1364 Fountain NB, 1534 Hekster YA, 1364 Deetha TD, 1027 Free SL, 352 Helms G, 290 DeGiorgio CM, 1195 Frey M, 1310 Henkel A, 818, 1153 Del Bigio MR, 655 Frick A, 1102 Hennessy MJ, 59 del Mar Pérez-Delgado M, 1259 Friedrich T, 1068 Henry T, 1195 Dell C, 1400 Frisén L, 1289 Henry TR, 316 DellaBadia J, 479 Fritz B, 1039 Herrendorf G, 71, 1574 Demirbilek V, 405 Frost FJ, 1020 Herzog AG, 34 Dennison H, 732 Frucht MM, 1534 Hesdon B, 1357 Derry PA, 177 Fuchs M, 1574 Hill MW, 1241 Dervent A, 405 Fujii T, 52 Hiramatsu M, 1091 Devinsky O, 400 Fujikawa DG, 981 Hirose S, 52 Dey H, 1560 Fujiwara T, 1584 Hirsch J, 400 Dickson WA, 453 Ho RT, 542 Diedrich A, 479 Gaillard WD, 1227 Hoch DB, i70 Dierckx R, 601 Gall CM, 493 Hoffman DA, 1072 Dodd RH, 651 Ganaxolone Presurgical Study Group, 1187 Holden L, 732 Doelman J, 1167 Garattini L, 110 Holmes GL, 34, 1051 Donati G, 1485 Garcia-Marin V, 1259 Homsma SJM, 110 Dongmo L, 432 Gassmann-Mayer C, 1167 Hoénack D, 1499 Doyle W, 400 Gatti G, 222 Hong K-S, 1450 Drislane FW, 536 Gauer LJ, 868 Hong SB, 207, 1554 Drury I, 316, 1330 Gause D, 1020 Hoppe M, 564 Drzezga A, 818 Geller E, 457 Hori A, 34 Dubeau F, 666, 825, 832 Gentsch K, 925 Hrachovy RA, 1078 Dubinsky S, 342 Geyer J, 1330 Huang C-C, 412 Duchowny MS, 1206 Gillespie GW, 1095 Hufnagel A, 467 Duhaime A-C, 903 Gilliam F, 963, 1474, 1546 Hughson C, 1167 Dumas M, 432 Gilliam FG, 1626 Huguenard JR, 1076 Diimpelmann M, 467 Gilman J, 1206 Huk WJ, 282 Duncan JS, 352 Gilmartin R, 1195 Hulsman J, 1167 Duncan R, 1167 Girvin JP, 1321 Hurley JS, 1020 Dunn DW, 615 Gizard F, 363 Huster GA, 615 Dunoyer C, 1206 Gobbelé R, 1574 Hyder F, 675 Dworetzky BA, 170 Goldberger AL, 536 Goldsmith IL, 395 Ikeda A, 1411 Eberhardt KWE, 282 Gondo K, 1642 Ikeda K, 1642 Ebers GC, 132 Gonzalez-Feria L, 1259 Inoue T, 1642 Ebert U, 372 Gonzalez-Gonzalez ML, 1259 Inoue Y, 1584 Epilepsia, Vol. 41, No. 12, 2000 AUTHOR INDEX Isnard J, 68] 1651 Isojarvi JIT, 42 Kotagal P, 457, 554, 971, 1474 IIttoa baMs,h i 52H H. 981 KKroazlgoewlsokhi- MaPn. n 655I , 628 LLoonngd onLo, 72A7. 1546 IIwvaest a JRH,, 55326 KKKrrriaaeumgssestr e iJnML ,, A1R95,59 07 1080 LL]o éossrsciihnuegs r DMWWI.,. 397]1 24,4 4 516, 1499 JJJJJJaaaaaaynlncclzanoko ucb nzhy DzaC ,inRP ,d,A 1r, G61 a.878n9 9748 3 2,. 2D 2.1 1] 31110952 7 KKKKKrrKuuriribbiussoiephhltspn nac a haRm EmIF,uo,, Cr o ,t1r 985h0t5119yh040 y 6 8 KBE,S , 53166 08 LLLLLiuooéihztwdatmeergnnaseotn n hn aH lOJA, . MH .J5.A 85, 86 1476,183 1177 997 ]. | 153 JJJJJJJoJoJoJooosienkeahbthnmeenysnyatseltan sns an ketcn eIakoJheBCz,rne V,sC n, s.T1 se 4PFJD1-,,5n,1.95 S 3 2 57c 11 111h124S5,0iI080 6,n7 6 828k 9e18]2. 8 9 A1,1 393 26 KKKKKKKKKwuKuuuuuuzuazurnnibnbnnblikoiuoio eek e evvdmaccaIaaaK Ck,k , nSyy P,n1 ,HTH 07 .,,11 4R R414GI2,3 1.,1]1 24 2 3]913655 6]54983 , 48, , 11315764526 6 MMMMMMMaMaMMaaaaararanalliheeegcdimhesshahosagr canzarrra raoreaPe utai ,Jnxt a ,K i RTL1T .A1,2. CKW,3 3 ,,P2.9 5 , 4 .16 ]9 45314 38|56233 931 18 2 ,329 79 5 6 42 Markand ON, 749 KaKKKKKKsKaKaKKaKaatapaaanananeninllnnkkagltsleeeduise aékkmre rainnaoo Da m yj tY-w n A,SoBHaW-S, M,, TtN,,P ., ,oa1 8 8 4Kl6n5552.46426sa 4] 3125 t1 2 0 3 1 1P00Ty3 r6e4 n5i7t é DGA. 1335 LLLLLLLLaaLaLaLaLaaaasuwaraPannnicngsdbgrbcgraaseifeeaasrooinyrsnrsoastnel t ntttc ruo eo h JD nrsMS ,-dJD ,CD MET R ,,J.,,PJ. | M T1,A ,192L|L76997 8, 316,515]19 440]9 3 |22 5 10 1 14 049234 6 MMMMMMMaMMaMaMaMaaataatatatarsisrrhhrerttrltcteerssiiarqihrjaonhnionuana n n ie eazVRRWnGc,PEG C, AoRo, , .wGn .vI R9.,z1,5 o5.6 4d 85 313l1848.625 e14 1P 21 8z32,363 1 59147051 M446.3 6 1005 KKKKKeeaaaltmwtlzaeoia snrway Tak ,yHi , A 7A1PJ14,,.3 9110001 433968, 2 1053 LLLLLeaaaaezxww aesnzrCo z Lne,Kr N ,,a J 1A011.M715 ,884 776 6 151,0 1456. 1540 MMMMMaaaaatuttttgssssuuuuoiuddnéraa ra eR YKHT,..,F ,9 21266549788 5 4} Key Ser A, 1364 Lee DA, 1187 May T, 564 Khan AA, 594 Lee DS, 65 Maytal J, 219, 959 Kifune A, 909 Lee D-S, 955 Mayville C, 39] KKiilkeuyc hiM A,S , 919693 3 LLeeee KKSH., 419434 4 MMcazAanraaltliy AML,. 1514203 KKiimm HB,G ,9 5655 LLeeee SS--HA., 925957 MMccCAaulbeey PHJ,W , 90764 4 Kim J-Y, 65. 1450 Lee SK, 65. 955, 1450 McGeer PL. 10 Kim K-w, 207 Lee W-o, 65 McInerney J, 57] KKKiiimmm SSS-E, K,, 7 62009 75.5 1554 LLLeeeihebnssetromtnaz CJ,K, . 534489121 MMMcccLLKaeicanhnnl oanJn, 1DR0.S4 .4 1 017302 , 177, 1321 Kimura H, 10 Lekvall A, 290 McMullen W. 400 King DW, 1444 Leppert M, 1066 McNulty P, 1119 KKKKKiiiiivttrriavaatde yyas a Rkm,aSa Kr,, i1 61M945,E422. ] 2 912299 6 LLLLLiheee awsvLtiayoMfs of, r SePR S,6, D6 E,61,. 11 9243568 4 93208 5 ,, 1853922 MMMMMeeeeeliilatneazdaremorkrerdo d ir CdKC JHS,... H .9 1110943633463 445 KKlleeiinnr oPk, 3Z4, |] 12 LLiik hXo-dLi,i 1S5S1.4 1400 MMeenndakoenrc a M.A , 50124 00 KKKKonnnbuuaatdkyssease sonhnS i , FEU1,K,0 ,3 39052 82 LLLLiiiinnnmd ddibiSne Sgr,eg NreA2 r.6 G 3, M 1,3 145261 72 89 MMMMeeeetrnnilk doeobBsz L a,P D, I1D 2.18 ,4 321643 09 0 Kogure §, 929 Lindsten H. 1469 Meyer FB, 843 KKoolhl e S,R , 12710,6 1574 LLiipotwa koKv,a 12S2, 7 788 MMiieclhkeel ucJc,i 10R4.4 967 Komatsu M. 109] Liu H-G, 594 Migliaretti G, 694 Kopylev L, 1227 Liu Z, 34 Mikati MA, 880 KKoorrpkemlaazin enB . J4T0,5 42 LLooigsee auJ H,P , 85| 179 MMiitkcuhneil l N,W G.14 1]1 616 Lombroso CT, 245. 122] Mitsudome A. 52 Mizrahi EM, 1049 Epilepsia, \ ol. 41, No. 12, 2000 1652 AUTHOR INDEX Mohamed A, 971 Ojha B, 594 Resnick TJ, 1206 Mohamed E, 1027 Okumura A, 714 Reynolds TF, 342 Mohapel P, 1095 Okuno T, 52 Rho JM, 862 Monaco F, 222, 694 Olafsson E, 1201 Rhodes HC, 1139 Monaghan EP, 1187 Olthof T, 326 Riaz H, 1167 Mononen T, 1214 Ong HT, 1474 Ridsdale L, 1014 Moore A, 1597 Oostra BA, 19 Riethmiiller J, 628 Moore JL, 727, 744 Oostrom KJ, 326 Riikonen R, 705 Moorjani BI, 457 Opeskin K, 48 Risinger MW, 320 Morawetz R, 963, 1546 Osorio I, 887, 1195 Ristanovic R, 1195 Morawetz RB, 1626 Ostrowsky K, 681 Roach J, 727 Morgese G, 1432 Overweg J, 1167 Robert E, 1436 Morrell MJ, 81, 320, 1187 Roberts DW, 571, 898, 1139 Morris GL, 1195 Pacia S, 400, 760 Robertson KA, 1420 Morris H, 971 Palmer CA, 1626 Rocca WA, 342 Morrison G, 1206 Pandian JD, 1027 Roh SY, 1554 Mosewich RK, 843 Park S-H, 1450 Rosano A, 1436 Moshé SL, 788 Park YD, 1444 Rose KJ, 177 Mott D, 744 Parra J, 1310 Rosenberg HJ, 447 Mountz JM, 594 Partanen J, 1214 Rosenberg SD, 447 Mueller RM, 332 Pascarella R, 1432 Rosenow F, 1039 Mulder OG, 1167 Passarelli D, 967 Ross DA, 316 Mulley J, 529 Pataraia E, 1567 Roéssler A-S, 651 Mundanda T, 1044 Patel M, 950 Rothman DL, 675 Mujfioz Hoyos A, 1005 Patsalos PN, 1364 Rothman SM, 1241 Murphy J, 1195 Pauli E, 282 Rousset C, 794 Murphy P, 862 Paulus W, 71, 1574 Rowan AJ, 105 Murro AM, 1444 Pavol M, 1321 Rumia J, 1303 Musa K, 1400 Peltzer JN, 887 Rundfeldt C, 28 Mustonen K, 1214 Pereira J, 1540 Rybicki L, 457 Musumeci SA, 19 Perrine K, 400 Ryvlin P, 681 Mykletun A, 802 Perucca E, 222, 1485 Myllyla VV, 42 Saab R, 880 Petersen HV, 1020 Sabaz M, 765 Na DG, 207 Petroff OAC, 675 Sachdev MS, 718 Nagelberg J, 950 Peyster RG, 148 Sadato A, 1411 Najm IM, 971 Pfander M, 1153 Salanova V, 749 Nakagawa E, 10 Piccinelli P, 1485 Salinsky M, 1195 Nam H-W, 1450 Pickering CT, 727 Salinsky MC, 332 Namer IJ, 642 Pitzalis S, 967 Salmanson E, 170 Narayanan V, 453 Pledger G, 1167 Sam MC, 1494 Naritoku DK, 1195 Pledger GW, 440 San Pedro EC, 594 Ndonko F, 432 Polizzi G, 1592 Sander JW, 1633 Negoro T, 714 Polkey CE, 1346 Sander JWAS, 338, 1592 Nehlig A, 363, 642 Pool F, 624 Sandok EK, 1315 Nei M, 542 Poolos NP, 1072 Santavuori P, 1296 Nergardh A, 308 Post RM, 1514 Santhoshkumar T, 1027 Neubauer BA, 1061 Postma G, 581 Sarma PS, 1027 Neuroimaging Subcommission of the Postma T, 1514 Savic I, 290 International League Against Epilepsy Prats A, 1206 Sawrie S, 1546 (ILAE), 1350 Preux P-M, 432 Sawrie SM, 1626 Newmark ME, 342 Prince DA, 1085 Scaramelli A, 1597 Newton MR, 463 Pulliainen V, 421 Schachter SC, 1195 Ney G, 1195 Schafer I, 282 Ngouafong P, 432 Qiao M, 655 Scheffer IE, $29, 1059 Nheu N, 765 Quigg M, 502, 1534 Scheier LM, 1616 Niemann G, 628 Scheuer ML, 193 Nikakhtar N, 1330 Racacho LJ, 132 Schiff DP, 193 Noachtar S, 818, 1153 Radhakrishnan K, 1027 Schijns O, 467 Nobile C, 967 Ragheb J, 1206 Schmitz B, 925 Nobili L, 201 Ramos Lizana J, 1005 Schober O, 588 Noda A, 941 Rancel-Torres N, 1259 Schomburg U, 1039 Noebels JL, 24, 1049, 1074 Ransil BJ, 34 Schomer DL, 536 Novak G, 219, 950 Raol YH, 128 Schottler F, 493 Nystrém L, 1469 Rating D, 1284 Schouten A, 326 Reed R, 1195 Schramm J, 140, 1249 O’Brien PC, 843 Reed RC, 887 Schroeder BC, 1068 O’Brien TJ, 843, 1315 Reeves AL, 727, 744 Schuchmann S, 635 O’Connor S, 601 Reissmiiller E, 372 Schuh LA, 316, 1330 Oda M, 1489 Remmel RP, 850 Schuierer G, 588 Oertel WH, 1039 Renier WO, 1364 Schulz R, 564 Ohara S, 1411 Rentmeester TW, 1167 Schulze-Bonhage A, 186 Ohman I, 709 Renzi C, 1436 Schumacher TB, 1249 Epilepsia, Vol. 41, No. 12, 2000 AUTHOR INDEX 1653 Schwaner C, 1534 Su M-S, 1162 Vigevano F, 482 Schwartz TH, 1463 Suchomelova L, 1375 Vitols S, 709 Schwarz P, 781 Sumiyoshi Y, 1436 Vogrin S, 1456, 1540 Seibyl JP, 1560 Sun L, 263 Voigt B, 941 Selwa LM, 1330 Sunstad L, 895 Volosov A, 1107 Seo DW, 207, 1554 Suominen K, 42 Vonck K, 601 Serikawa T, 941 Swann JW, 1078 Vuilleumier P, 687 Serles W, 1567 Swinkels WAM, 1335 Seshia SS, 655 Sze G, 148 Waaler PE, 802 Seyfried TN, 933 Waberski TD, 71, 1574 Shackleton DP, 1335 Taki W, 1411 Wagner AK, 170 Shanahan CW, 170 Tamir A, 1522 Wakat J-P, 1039 Sharbrough FW, 843 Tanaka M, 1584 Walczak TS, 760 Sharpe JA, 1637 Tandon P, 933 Walden J, 1102 Shatz R, 1046 Tarletti R, 694 Walker EB, 1597 Shibasaki H, 1411 Tassi L, 482 Walters GL, 992 Shibata N, 909 Tassinari CA, 967 Wang S-T, 412 Shih JJ, 213 Taylor RB, 1637 Wasterain CG, 123 Shimada M, 10 Tecoma E, 1195 Watanabe K, 714 Shimizu H, 1489 Tenembaum SN, 380 Watanabe Y, 1584 Shinmei SS, 981 Testa FM, 1269 Watzka M, 140 Shinnar S, 760, 1269 Thadani VM, 571, 898, 1139 Weckesser M, 588 Shorvon SD, 231, 1179 The RESt-1 Group, 998 Weis S, 818 Siegel AM, 571, 1139 Theodore WH, 1227 Weiss SRB, 1514 Siegmund H, 635 Thomas J, 963 Weissinger F, 635 Sillanpaéaé M, 110 Thomas SV, 1027 Weitz R, 1522 Sills GJ, 977 Thompson J, 1195 Wennberg RA, 1637 Silveira DC, 34 Thompson PJ, 231 Werhahn KJ, 818, 1153 Singh G, 718 Thorbecke R, 110 Wheless J, 1195 Sisodiya SM, 352 Tiemagni F, 432 Whelihan E, 749 Skeidsvoll H, 802 Tirath A, 718 Whiting SE, 1206 Skutova M, 1235, 1375 Todorova MT, 933 Wide K, 854 Smith B, 1046 Tofani A, 1485 Widman G, 811 Smith BJ, 316 Tolle TR, 818 Wild JM, 1420 Smith JW, 1444 Tolonen U, 42 Williamson PD, 447, 571, 898, 1139 Smith KL, 1078 Tomandl B, 282 Willmore LJ, 1091 Smith SJM, 1633 Tomson T, 709, 854, 1289 Winbladh B, 854 Smith-Rapaport S, 1269 Tooyama I, 10 Winkler PA, 818, 1153 So EL, 342, 843, 1315, 1494 Torres X. 1303 Wolf C, 1284 So NK, 213 Tortorelli S, 201 Wolff M, 628 Sofia RD, 123 Townes BD, 405 Wolford GL II, 447 Song Hc, 65 Townsend DW, 193 Wolgamuth B, 554 Sonnen AEH, 110 Trimble MR, 1608 Wong ICK, 338, 1592 Sotero de Menezes MA, 862 Tsai J-J, 412 Wong M, 271, 1241 Spanaki MV, 1227 Tuhrim S, 105 Woolley CS, 510 Spencer DC, 320 Tuor UI, 655 Wroe S, 1167 Spencer DD, 297 Turk WR, 426 Wu A, 981 Spencer SS, 297, 760, 1560 Tuxhorn I, 564 Wyllie E, 554, 971, 1474 Sperling MR, 542, 760 Stafstrom CE, 933 Urbach H, 811 Yagen B, 1107 Stanford L, 554 Uthman B, 1195 Yagi K, 1584 Stavem K, 85, 91 Yagishita A, 1489 Steele R, 219 Van Cott A, 193 Yamada K, 1584 Stefan H, 282, 1597 Van Hammée G, 868 Yamada KA, 271 Steffens R, 1249 Van Laere K, 601 Yamazoe H, 941 Stein V, 1068 Van Rijn CM, 1364 Yang L, 1507 Steinhauser C, 1249 van Veelen CWM, 581 Yasuhara O, 10 Steinhoff BJ, 71, 1574 Vandekerckhove T, 601 Yen D-J, 1162 Steinlein OK, 529 Vanhatalo S, 705 Ying Z, 971 Stephen LJ, 977 Varrasi C, 694 Yiu C-H, 1162 Stevens JM, 352 Vaughn B, 1195 Yousry TA, 818 Stichel CC, 781 Vazquez Lopez M, 1005 Yu H-Y, 1162 Stilma JS, 581 Velasco AL, 158 Stoffel-Wagner B, 140 Velasco F, 158 Zagon A, 1382 Stokking R, 1560 Velasco M, 158 Zampino G, 1436 Stoodt J, 529 VeliSek L, 788 Zanette G, 1129 Storzbach D, 332 VeliSkova J, 788 Zentner J, 467 Straume M, 502 Venault P, 651 Zhou X-Y, 1102 Studholme C, 1560 Verduin WM, 581 Ziegler RG, 732 Sturm JW, 463 Vergnes M, 794 Zis FY, 913 Sturm K, 1039 Verrotti A, 1432 Zubal IG, 1560 Sturm Y, 1597 Vickrey BG, 760 Zupanc ML, 395 Epilepsia, Vol. 41, No. 12, 2000 Epilepsia, 41(12):1654—1668, 2000 ums & Wilkins, Inc., Baltimore Internati League Against Epilepsy Epilepsia Vol. 41, 2000 Subject Index Absence seizures. See Seizures. unsuccessful testing in preadolescent children, 554 Absorption in Wada test, contralateral EEG slowing, 207 rectal, of lamotrigine compressed tablets, 850 Amygdala kindling Abuse claustral lesions, 1095 trauma and posttraumatic stress disorder, in seizure patients, 447 lamotrigine effect on seizures, 1514 Accident prevention levetiracetam tolerance, 1499 burn treatment, in epilepsy, 453 7-nitroindazole effects on antiepileptic drugs, 1112 psychogenic nonepileptic seizures, 895 repeated acute testing of anticonvulsant drugs, 516 social factors of epilepsy, in Europe, 998 Aneurysm N-Acetyl aspartate (NAA) subarachnoid hemorrhage, risk of epilepsy, 1201 frontal lobe, juvenile myoclonic epilepsy, 290 Animal studies in newly diagnosed partial epilepsy, MR spectroscopy, 825 antiepileptic drug polytherapy, mechanisms of action, 1364 Acidosis dog, 10-hydroxycarbazepine enantiomers, comparative pharmaco- renal tubular, with zonisamide therapy, 1642 kinetics, 1107 Adherence guinea pig, hippocampus, lamotrigine effects on field potentials to treatment, childhood epilepsy, 1616 and Adolescents long-term potentiation, 1102 psychosocial and neurologic care of children with seizures, 732 mouse, audiogenic seizures, fragile X syndrome, 19 Adverse effects mouse, benzodiazepine binding in subkindling, 651 epilepsy-related quality of life, levetiracetam effects, 868 mouse, epileptogenesis inhibited by ketogenic diet, 933 frontal nonconvulsive status epilepticus with tiagabine therapy, mouse, hippocampal MRI in mesial temporal lobe epilepsy, 642 familial bilateral perisylvian polymicrogyria, 1485 mouse, hippocampal-entorhinal slices, cooling effects on seizures, intracranial electrodes, 898 1241 lamotrigine-induced tic disorder, in children, 862 rabbit, simultaneous kindling of bilateral hippocampi, epilepsy nystagmus, and deep brain stimulation, in epilepsy, 1637 model, 929 phenobarbital and primidone cross-tolerance, 1310 rat, amygdala kindling, 7-nitroindazole effects on antiepileptic renal tubular acidosis, with zonisamide therapy, 1642 drugs, 1112 topiramate, in refractory epilepsy, 977 rat, amygdala kindling, vigabatrin effects on sleep, 128 topiramate, in refractory partial epilepsy, 1162 rat, anticonvulsant drug testing in amygdala kindling, 516 topiramate vs. valproate add-on therapy to carbamazepine, cogni- rat, brain, zonisamide reduction of 8-OHdG during epileptogen- tive esis, 1091 function in partial-onset seizures, 1167 rat, claustrum, amygdaloid kindling, 1095 vagus nerve stimulation, refractory seizures, 1195 vagus nerve stimulation, tonsillar pain, 903 rat, cortical neurons, vagus nerve stimulation, slow hyperpolariza- tion, 1382 valproic acid-induced hyperammonemic encephalopathy, with tri- rat, cyclosporine induction of epileptiform activity, 271 phasic waves, 909 rat, developing, anticonvulsant actions of tiagabine, 1375 vigabatrin-induced visual field constriction, 1420 rat, developing, ganaxolone effect on flurothyl seizures, 788 Affective disorder rat, developing, topiramate effect on motor seizures, 1235 after temporal lobectomy, 1608 rat, entorhinal cortex, low magnesium-induced seizures, fenflur- Age factors amine effects, 925 childhood epilepsy, 802 rat, estrogen effect on kainic acid seizures, 510 nitric oxide role in pentylenetetrazol seizures, 363 rat, felbamate effects on status epilepticus, 123 psychosocial and neurologic care of children with seizures, 732 rat, GAERS model, nitric oxide role in sleep and epilepsy, 794 Amino acids rat, hippocampal sclerosis, theophylline and trimethobenzamide CHRNAG4 Ser248Phe mutation, nocturnal frontal lobe epilepsy, effects, 1390 529 rat, ketogenic diet, dietary fat, ketosis, and seizure resistance, valproic acid-induced hyperammonemic encephalopathy, with tri- 1400 phasic rat, lamotrigine during amygdala-kindled seizures, 1514 waves, 909 rat, lateral symmetry with unilateral amygdaloid seizures, 34 y-Aminobutyric acid. See GABA y-aminobuiyric acid). rat, levetiracetam tolerance, amygdala kindling, 1499 4-Aminopyridine rat, limbic epilepsy, circadian regulation of seizures, 502 seizures, optical signals, 635 rat, NER strain, tonic-clonic seizures, chromosomal mapping for Amnesia epilepsy genes, 941 after temporal lobectomy, intracarotid amobarbital procedure, 1321 rat, neuronal migration disorders in neocortical structures, 781 Amobarbital rat, nitric oxide role in pentylenetetrazol seizures, age effects, 363 intracarotid, cognitive function after ATL, 922 rat, optical signals in low Mg?*- and 4-aminopyridine-induced intracarotid, global amnesia after temporal lobectomy, 1321 seizures, 635 lateralization of seizure focus, 65 rat, progenitor cell division in dentate gyrus, induction by limbic patient evaluation for epilepsy surgery, 320 seizures, 10 SUBJECT INDEX 1655 rat, retigabine in magnesium-induced epileptiform activity in ento- neurocognitive, in childhood epilepsy, 426 rhinal cortex hippocampus, 28 vigabatrin long-term effects, developing brain, 655 rat, SGB-017 blockage of voltage-gated sodium channels, vs. car- Benzodiazepine bamazepine, 263 binding in subkindling, 651 rat, subcortical band heterotopia, seizure activity, 493 receptor binding, seizure onset zone in extratemporal focal cortical rat, topiramate in kindling model, 372 dysplasia, 818 rat, valproate prevention of epilepsy, after neocortical trauma, Bioavailability 1507 lamotrigine compressed tablets, rectal absorption of, 850 rat, vigabatrin long-term effects on immature brain, 655 Body dimensions Anterior temporal lobectomy (ATL) fetal growth, exposure to antiepileptic drugs in utero, 854 intracarotid amobarbital, and cognitive function, 922 Bone Antiepileptic drugs See also specific agents. cortical dysplasia with ossification, 1489 availability in Cameroon, 432 Book Reviews benign focal childhood epilepsy, 1057 The Brainstorms Woman: Epilepsy in Our Lives, 484 costs of epilepsy treatment, 342 Dysplasia of Cerebral Cortex and Epilepsy, 484, 776 epilepsy and juvenile neuronal ceroid lipofuscinosis, 1296 The Epilepsies. Etiologies and Prevention, 256 metabolic changes in bifrontal epilepsy, 588 Epilepsy: The Comprehensive CD-ROM, 775 7-nitroindazole effects, in amygdala kindling, 1112 Epilepsy, The Indian Perspective, 484 number-needed-to-treat method, in trials, 440 Essentials of Clinical Epilepsy, Second Edition, 255 polytherapy, mechanisms of action, 1364 Fast Facts: Epilepsy, 486 quality of life and behavior outcome, methodology and reporting Genetics of Focal Epilepsies, 254 standards, 1357 Goldensohn’s EEG Interpretation: Problems of Overreading and quality of life measurement, in children, 765 Underreading, 2nd Completely Revised Edition, 254 referral patterns of primary care physicians, 744 Magnetic Resonance Spectroscopy Diagnosis of Neurological Dis- renal tubular function, 1432 eases, 776 repeated acute testing in amygdala kindling, 516 Medically Refractory Epilepsy, 1645 teratogenesis, 1436 The Practice of Neurosurgery, 775 therapeutic drug monitoring, newly diagnosed epilepsy, 222 A Textbook of SPECT in Neurology and Psychiatry, tN anN n trials in private clinical practice, 875 Brain in utero, fetal growth, 854 cerebral and cerebellar volume reduction, childhood epilepsy, vigabatrin-induced intramyelinic edema, 148 1456 Aphasia cortical dysplasia with ossification, 1489 BCECTS, atypical evolution, 380 CT, emergency evaluation of children with seizures, 950 familial, variant of partial epilepsy, 1036 development, intrinsic circuits, 1082 Landau-Kleffner syndrome, immunoglobulin monotherapy, 880 development, neurotransmitter actions, 1080 Apnea entorhinal cortex, low magnesium-induced seizures, fenfluramine postictal central, SUDEP, 1494 effects, 925 Arachnoid cyst GABA, homocarnosine, and pyrrolidinone, gabapentin effects, 675 seizures in head injury, 243 immature, vigabatrin long-term effects, 655 Arrhythmias metabolism, ictal FDG PET, of extratemporal epileptic foci, 193 interictal cardiovascular autonomic responses, temporal lobe epi- metabolism and perfusion, uncoupling of, PET and SPECT ratio- lepsy, 42 images, 1560 partial seizures in refractory epilepsy, 542 neocortical, neuronal migration disorders, 781] Asthma subcortical band heterotopia, seizure activity, 493 and childhood epilepsy, gender and behavior problems, 615 volume reduction, predictors of, in childhood epilepsy, 1456, 1540 Ataxia, spinocerebellar zonisamide reduction of 8-OHdG during epileptogenesis, 1091] calcium channel gene CACNG2 localization, 24 Breast milk Attention lamotrigine pharmacokinetics, 709 neurocognition and behavior, febrile convulsions, 412 Burns Audiogenic seizures in epilepsy patients, 453 fragile X syndrome, 19 Byzantine medicine Auditory system epilepsy of Emperor Michael IV, Paphlagon, accounts of histori- autosomal dominant partial epilepsy, 967 ans and physicians, 913 Auras frontal lobe epilepsy, intractable seizures, 1139 Calbindin Automatism in inhibitory interneurons, neuronal migration disorders, 781 frontal lobe epilepsy, intractable seizures, 1139 Calcification Autonomic nervous system focal cortical-subcortical, and epilepsy, 718 cardiopulmonary instability, oxygen desaturation in partial sei- Calcium channels zures, 536 in dentate gyrus neurons, modulation by glutamate receptors, tem- interictal cardiovascular responses, temporal lobe epilepsy, 42 poral lobe epilepsy, 1249 in inherited generalized epilepsy, 1074 Carbamazepine BCECTS (benign localization-related epilepsy in children) and fetal growth, exposure in utero, 854 atypical evolution, 380 and phenytoin, in refractory idiopathic absence status epilepticus, 887 Behavior renal tubular function, 1432 adherence to treatment, childhood epilepsy, 1616 repeated acute testing, amygdala kindling, 516 and antiepileptic drugs, methodology and reporting standards, vs. SGB-017 (ADCI) blockage of voltage-gated sodium channels, 1357 263 childhood epilepsy and asthma, gender role, 615 topiramate vs. valproate add-on therapy, cognitive function in estrogen effect on kainic acid seizures, 510 partial-onset seizures, 1167 and loss of consciousness in absence seizures, 687 Cardiovascular system neurocognition, febrile convulsions, 412 interictal autonomic responses, temporal lobe epilepsy, 42 Epilepsia, Vol. 41, No. 12, 2000 1656 SUBJECT INDEX Cavernous sinus mapping for epilepsy genes, tonic-clonic seizures, 941 EEG, seizures on mesial temporal lobe epilepsy, 1411 18q- deletion syndrome, autonomic seizures vs. syncope, 1039 Cell death Cingulate gyrus epilepsy in status epilepticus, without epilepsy, 981 SPECT localization of seizures, 594 Cerebellum Circadian rhythm atrophy, in temporal lobe epilepsy, 1315 seizure regulation, limbic epilepsy, 502 volume reduction, in childhood epilepsy, 1456 Classification volume reduction, predictors of, in childhood epilepsy, 1540 cerebral and cerebellar volume reduction, in childhood epilepsy, Cerebral cortex 1456 nitric oxide synthase, in epilepsy, 1259 childhood epilepsy, 802 Cerebrospinal fluid (CSF) epilepsy diagnosis, reassessment after 2 years, 1269 nitrate/nitrite, in PEHO syndrome, 705 occipital paroxysms, childhood epilepsy, 1522 Chemotherapy Claustrum and intracranial electrode complications, 898 lesions, and amygdaloid kindling, 1095 Children and infants Clinic attendance atypical evolution in BCECTS, 380 leader education, 1044 benign familial neonatal convulsions, potassium channel genes, Clinical studies 1066 absence seizures, behavioral and EEG topographic correlates of benign focal epilepsy, clinical spectrum, 1051 loss of consciousness, 687 benign focal epilepsy, drug treatment, 1057 absence seizures, tonic-clonic activity, 391 benign focal epilepsy, genetically determined pathophysiology, acute seizures, rapid intravenous loading of valproate, 1342 1085 amnesia after temporal lobectomy, intracarotid amobarbital proce- benign focal epilepsy, workshop report, 1049 dure, 1321 brain CT, emergency evaluation of seizures, 950 amobarbital, patient evaluation for surgery, 320 clonazepam effects, 308 anterior cingulate gyrus epilepsy, SPECT localization, 594 diagnosis of epilepsy, first seizures, 1230 anticonvulsant therapy, and renal tubular function, 1432 drug-induced metabolic changes in bifrontal epilepsy, 588 antiepileptic drugs, quality of life and behavior outcome, method- early postictal EEG, complex febrile seizures, 219 ology and reporting standards, 1357 epilepsy, adherence to treatment, 1616 antiepileptic therapy in Cameroon, 432 epilepsy, and asthma, gender and behavior problems, 615 asymmetric tonic limb posturing, in tonic-clonic seizures, 457 epilepsy, and neurocognitive behavior, 426 atypical evolution in BCECTS, 380 epilepsy, cerebral and cerebellar volume reduction, 1456 autonomic dysfunction in temporal lobe epilepsy, 42 epilepsy diagnosis, reassessment after 2 years, 1269 autonomic seizures, vs. syncope, in 18q- deletion syndrome, 1039 epilepsy, and juvenile neuronal ceroid lipofuscinosis, antiepileptic autosomal dominant nocturnal frontal lobe epilepsy, 52 drug therapy, 1296 autosomal dominant partial epilepsy, auditory features, 967 epilepsy and mental retardation, 1214 bitemporal independent interictal epileptiform discharges, in tem- epilepsy, occipital paroxysms, 1522 poral lobe epilepsy, 213 epilepsy, predictors of hippocampal, cerebral, and cerebellar vol- burns and epilepsy, 453 ume reduction, 1540 calcification, focal cortical-subcortical, and epilepsy, 718 epilepsy, prevalence, classification, and severity, 802 cavernous sinus EEG, seizures on mesial temporal lobe epilepsy, epilepsy, quality of life, parent- and patient-validated content, 1411 1474 cerebellar atrophy, in temporal lobe epilepsy, 1315 exposure to antiepileptic drugs in utero, fetal growth, 854 chemical shift imaging spectroscopy, and memory function in juvenile myoclonic epilepsy, frontal lobe N-acetylaspartate, 290 temporal lobe epilepsy, 282 juvenile myoclonic epilepsy, intracortical inhibition, 1129 childhood epilepsy and asthma, gender and behavior problems lamotrigine-induced tic disorder, 862 615 Landau-Kleffner syndrome, immunoglobulin monotherapy, 880 childhood epilepsy, cerebral and cerebellar volume reduction, neonatal epilepsy and progressive deafness, KCNQ channels, 1068 1456 neurocognition and behavior, febrile convulsions, 412 childhood epilepsy, occipital paroxysms, 1522 occipital lobe epilepsy, neuropsychological factors, 405 childhood epilepsy, prevalence, classification, and severity, 802 partial epilepsy, early recognition, 714 clonazepam effects in children, 308 pavor nocturnus, epileptic origin, 1221 cluster analysis, semiology of nonepileptic seizures, 610 PEHO syndrome, CSF nitrate/nitrite, 705 cognitive function, topiramate vs. valproate as add-on therapy to perinatal head injury, cortical dysplasia, 245 carbamazepine, partial-onset seizures, 1167 preadolescent, unsuccessful amobarbital testing, 554 congenital bilateral perisylvian syndrome, epileptogenesis, 1584 quality of life measurement, 765 contralateral EEG slowing and amobarbital, in Wada test, 207 rolandic epilepsy, genetics of, 1061 contralateral secondary seizures, temporal lobe epilepsy, 1444 seizure recurrence, 1005 cortical dysplasia, early postnatal closed head injury, 245 seizures in rural Zambia, 277 cortical excitability, in cryptogenic localization-related epilepsy, shame and guilt, in epilepsy, 326 694 Status epilepticus, frontal nonconvulsive, tiagabine therapy in fa- cortical language distribution, cognitive function, 400 milial bilateral perisylvian polymicrogyria, 1485 diagnosis of epilepsy, first seizures, 1230 sulthiame monotherapy, benign childhood epilepsy with centro- dipole-source analysis, head model of focal epilepsy, 71 temporal spikes, 1284 drug-induced metabolic changes in bifrontal epilepsy, 588 teratogenic effects of antiepileptic drugs, 1436 early postictal EEG in children with complex febrile seizures, 219 tuberous sclerosis complex, presurgical evaluation, 1206 electrodes, intracranial, after failed invasive monitoring, 571 vigabatrin-associated encephalopathy, 628 emergency evaluation of seizures, brain CT in children, 950 CHRNA4 Ser248Phe mutation epilepsy after aneurysmal subarachnoid hemorrhage, 1201 nocturnal frontal lobe epilepsy, 529 epilepsy cost, 342 Chromosomes epilepsy diagnosis, reassessment after 2 years, 1269 autosomal dominant partial epilepsy, auditory features, 967 epilepsy and juvenile neuronal ceroid lipofuscinosis, antiepileptic chromosome 22q13, calcium channel gene CACNG2 localization, drug therapy, 1296 24 epilepsy and neurocognitive behavior, 426 Epilepsia, Vol. 41, No. 12, 2000 SUBJECT INDEX 1657 epilepsy-related quality of life, levetiracetam effects, 868 psychosocial and neurologic care of children with seizures, 732 epileptiform discharges in sleep, Landau-Kleffner syndrome, 201 psychosocial factors, epileptic seizures, WPSI study, 1335 extratemporal focal epilepsy, benzodiazepine receptor binding, Quality of Life in Epilepsy Inventory, Norwegian version, 91 seizure onset zone, 818 quality of life measurement in children, 765 familial aphasia, variant of partial epilepsy, 1036 reactive post-resection spikes, 1463 fetal growth, antiepileptic exposure in utero, 854 rectal absorption of lamotrigine compressed tablets, 850 flumazenil-induced partial epileptic seizures, 186 referral patterns of primary care physicians, 744 focal cortical dysplasia, transcranial magnetic stimulation, 240 refractory complex-partial status epilepticus, propofol treatment, frontal lobe epilepsy, intractable seizures, 1139 105 frontal lobe epilepsy, prediction of surgical outcome, 843 refractory epilepsy, quality of life, 749 functional mapping of insular cortex, 681 refractory epilepsy, seizure severity and quality of life, 760 gabapentin effects on brain GABA, homocarnosine, and pyrrolidi- remote memory in epilepsy, 231 none, 675 renal tubular acidosis, with zonisamide therapy, 1642 ganaxolone, anticonvulsant activity, 1187 SAHCS, and temporal lobe seizures and paroxysmal EEG, 158 genetic heterogeneity for febrile convulsions, 132 seizure precipitants, in epilepsy syndromes, 1534 health status in epilepsy, 85 seizure recurrence, in children, 1005 heterotopia, in refractory epilepsy, 352 seizures, head injury, 243 hypnotic seizure induction, 81 seizures in rural Zambia, 277 ictal FDG PET of extratemporal epileptic foci, 193 shame and guilt, in childhood epilepsy, 326 ictal SPECT, in temporal lobe epilepsy, 955 single seizure, effects on health status and health care utilization, ictal spiking, temporal depth electrodes, 316 170 ictal surface EEG and seizure semiology, lateralization in temporal source reconstruction, mesial temporal epileptiform activity, 1574 lobe epilepsy, 1567 spatiai distribution of neuronal complexity loss, in neocortical le- idiopathic generalized epilepsy, hemiconvulsive seizures, 1633 sional epilepsy, 811 immunoglobulin monotherapy in Landau-Kleffner syndrome, 880 status epilepticus, frontal nonconvulsive, tiagabine therapy in fa- intracarotid amobarbital, cognitive function after ATL, 922 milial bilateral perisylvian polymicrogyria, 1485 intracranial EEG seizure-onset patterns, neocortical epilepsy, 297 status epilepticus, refractory idiopathic absence, phenytoin and intracranial interictal spike activity, epilepsy surgery, 467 carbamazepine effects, 887 juvenile myoclonic epilepsy, intracortical inhibition, 1129 status epilepticus without epilepsy, neuronal loss, 981 lamotrigine, gabapentin, and topiramate retention rates, in epi- stigma of epilepsy, 98 lepsy, 1592 sudden death in epilepsy, prolactin levels, 48 lamotrigine pharmacokinetics, in pregnancy, 709 sulthiame monotherapy, benign childhood epilepsy with centro- lamotrigine-induced tic disorder, in children, 862 temporal spikes, 1284 Lennox—Gastaut syndrome, seizure outcome, MRI head imaging, surgical outcome in mesial TLE, and ictal scalp EEG propagation, 395 564 levetiracetam as add-on therapy, refractory partial seizures, 1179 temporal lobe epilepsy, 5a-reductase and 3a-hydroxysteroid levetiracetam tolerance, refractory partial seizures, 1276 oxidoreductase in hippocampus, 140 magnetic resonance spectroscopy, lateralization in temporal lobe temporal lobe epilepsy, MRI, mesial temporal sclerosis, surgical epilepsy, 832 outcome, 963 myoclonus, and gabapentin use, 479 temporal lobe epilepsy, preoperative emotional adjustment, and negative mood, and cognitive function, 421 postoperative depression, 177 neocortical epilepsy, ictal surface EEG, 1450 temporal lobe epilepsy, Wisconsin Card Sorting Performance, neocortical lesional epilepsy, spatial distribution of neuronal com- 1626 plexity loss, 811 teratogenic effects of antiepileptic drugs, 1436 neurocognition and behavior, febrile convulsions, 412 therapeutic drug monitoring in newly diagnosed epilepsy, 222 neuronal metabolic dysfunction in partial epilepsy, MR spectros- tonic seizures, lateralization in focal epilepsy, 1153 copy, 666 topiramate, in chronic epilepsy, 338 neuroticism after epilepsy surgery, 1303 topiramate, in refractory epilepsy, 977 newly diagnosed unprovoked epilepsy, mortality risk, 1469 topiramate, in refractory partial epilepsy, 1162 nitric oxide synthase, in cerebral cortex in epilepsy, 1259 trauma and posttraumatic stress disorder, in seizure patients, 447 NMDA receptor subunit NR2A/B, and epileptogenesis in cortical tuberous sclerosis complex, presurgical evaluation in children, dysplasia, 971 1206 nonepileptic seizures, MMPI and EEG measures, 332 vagus nerve stimulation, in refractory epilepsy, 601 nonepileptic seizures, outcome factors, 1330 vagus nerve stimulation, refractory seizures, 1195 number-needed-to-treat method, in drug trials, 440 vagus nerve stimulation, tonsillar pain, 903 nystagmus induced by deep brain stimulation, in epilepsy, 1637 valproic acid-induced hyperammonemic encephalopathy with tri- occipital lobe epilepsy, ictal SPECT and interictal PET, 463 phasic waves, 909 occipital lobe epilepsy, neuropsychological factors, 405 vigabatrin vs. gabapentin, add-on therapy in partial seizures, 1289 occipitoparietal epilepsy, hippocampal atrophy, congenital devel- vigabatrin-associated encephalopathy, 628 opmental abnormalities, 1546 vigabatrin-induced intramyelinic edema, 148 oxcarbazepine, in refractory partial epilepsy, 1597 visual field, vigabatrin-induced constriction, electro-oculography, partial epilepsy, in infants, early recognition, 714 electroretinography, visual evoked potentials, 1420 partial epilepsy, newly diagnosed, MR spectroscopy, 825 visual field contraction, temporal lobe epilepsy, and vigabatrin patient knowledge of epilepsy, 727 medication, 58] patient-based assessment of NEWQOL, newly diagnosed epilepsy, Wada memory test, and temporal lobe glucose metabolism, 1554 1119 Wada memory test, lateralization of seizure focus, 65 PEHO syndrome, in children, CSF nitrate/nitrite, 705 Wada test, topiramate effects, 906 PET and SPECT ratio-images, uncoupling of brain metabolism Clonazepam and perfusion, 1560 in children with epilepsy, 308 phenobarbital and primidone, cross-tolerance, 1310 Cognitive function photogenic partial seizures, 59 and behavior, childhood epilepsy, 426 progressive myoclonus epilepsy, vagus nerve stimulation, 1046 cortical language distribution, 400 psychiatric outcome after lobectomy, 1608 intracarotid amobarbital after ATL, 922 Epilepsia, Vol. 41, No. 12, 2000 1658 SUBJECT INDEX Lennox—Gastaut syndrome, seizure outcome, MRI head imaging, Developing countries 395 antiepileptic drug availability in Cameroon, 432 and negative mood in epilepsy, 421 epilepsy, and focal cortical-subcortical calcification, 718 neuroticism after epilepsy surgery, 1303 India, prevalence, knowledge, attitude, and practice of epilepsy, topiramate vs. valproate as add-on therapy to carbamazepine, 1027 partial-onset seizures, 1167 seizures in rural Zambia, 277 Compliance Zimbabwe, leader education, clinic attendance, 1044 childhood epilepsy, adherence to treatment, 1616 Development patient knowledge of epilepsy, 727 anticonvulsant actions of tiagabine, 1375 psychosocial and neurologic care of children with seizures, 732 brain, vigabatrin long-term effects, 655 Computed tomography (CT) congenital abnormalities, occipitoparietal epilepsy, 1546 brain, emergency evaluation of children with seizures, 950 ganaxolone effect on flurothyl seizures, 788 epilepsy, and focal cortical-subcortical calcification, 718 neocortex, intrinsic circuits, 1082 intracranial interictal activity, presurgical epilepsy, 467 neocortical, neurotransmitter actions, 1080 Computer monitors. photogenic partial seizures, 59 neuroplasticity and epilepsy, 1078 Concussion nitric oxide role in pentylenetetrazol-induced seizures, age factors, seizures, 243 363 Congenital syndromes. See Genetic factors. teratogenic effects of antiepileptic drugs, 1436 Consciousness, loss of topiramate effect on motor seizures, 1235 absence seizures, behavioral and EEG topographic correiates, 687 Diagnosis Convulsions epilepsy, first seizures, 1230 benign familial neonatal, potassium channel genes, 1066 epilepsy, reassessment after 2 years, 1269 blows to head, 243 ILAE commission report on diagnostic strategies, functional neu- febrile, cognition and behavior, 412 roimaging in epilepsy, 1350 febrile, genetic heterogeneity, 132 Diaschisis Cortical dysplasia cerebellar atrophy, in temporal lobe epilepsy, 1315 NMDA receptor subunit NR2A/B, and epileptogenesis, 971 Diazepam perinatal head injury, 245 for febrile seizures, 2 subcortical band heterotopia, seizure activity, 493 Diet transcranial magnetic stimulation, 240 ketogenic, seizure resistance, 1400 Cost effectiveness Dipole-source analysis epilepsy treatment, 342 head model of focal epilepsy, 71 Counseling DNA patient knowledge of epilepsy, 727 autosomal dominant nocturnal frontal lobe epilepsy, 52 Cyclosporine fragmentation, progenitor cell division in dentate gyrus, induction induction of epileptiform activity, 271 by Cysticercosis limbic seizures, 10 epilepsy, and focal cortical-subcortical calcification, 718 Driving issues patient knowledge of epilepsy, 727 Database psychogenic nonepileptic seizures, 895 teratogenic effects of antiepileptic drugs, 1436 social factors of epilepsy, in Europe, 998 Deafness Drug interactions neonatal epilepsy, KCNQ channels, 1068 methsuximide effects on lamotrigine, 624 Death, sudden phenobarbital and primidone, cross-tolerance, 1310 oxygen desaturation and partial seizures, 536 refractory complex-partial status epilepticus, propofol treatment, vagal nerve stimulation by NCP system, 549 105 Deep brain stimulation Dysmyelination nystagmus induced by, in epilepsy, 1637 18q- deletion syndrome, autonomic seizures vs. syncope, 1039 Definitions, febrile seizures, 2 Dysplasia Demographics cortical, with ossification, 1489 antiepileptic drug retention rates, in epilepsy, 1592 clonazepam effects, in children with epilepsy, 308 Economics health care costs in epilepsy, 1020 cost of epilepsy, 342 health status in epilepsy, 85 health care in epilepsy, 1020 levetiracetam as add-on therapy, refractory partial seizures, 1179 trials in private clinical practice, 875 occipital lobe epilepsy, neuropsychological factors, 405 Edema patient-based assessment of NEWQOL, newly diagnosed epilepsy, vigabatrin-induced intramyelinic, 148 1119 Education remote memory, in epilepsy, 231 social factors of epilepsy, in Europe, 998 single seizures, impact on health status and health care utilization, Electrocardiography (ECG) 170 partial seizures in refractory epilepsy, 542 stigma of epilepsy in Europe, 98 Electrocorticography temporal lobe epilepsy, cerebellar atrophy, 1315 reactive post-resection spikes, 1463 Dendrites Electrodes and potassium channels, in hippocampal pyramidal neurons, 1072 cavernous sinus EEG, temporal lobe seizures, 1411 Dentate gyrus intracranial, after failed invasive monitoring, 571 calcium channel modulation by glutamate receptors, temporal lobe intracranial, complication of, 898 epilepsy, 1249 temporal depth, ictal spiking, 316 progenitor cell division, induction by limbic seizures, 10 Electroencephalography (EEG) Depression absence seizures, tonic-clonic activity, 391 and cognitive function, in epilepsy, 421 autosomal dominant nocturnal frontal lobe epilepsy, 52 postoperative, and preoperative emotional adjustment, temporal BCECTS (benign localization-related epilepsy in children), atypi- lobe epilepsy, 177 cal evolution, 380 Epilepsia, Vol. 41, No. 12, 2000

ebook img

Epilepsia 2000: Vol 41 Index PDF

21 Pages·2000·4.8 MB·English
by  
#periodicals #sim_microfilm #pub_epilepsia
Save to my drive
Quick download
Download
Upgrade Premium
Most books are stored in the elastic cloud where traffic is expensive. For this reason, we have a limit on daily download.

Preview Epilepsia 2000: Vol 41 Index

Epilepsia, 41(12):1649-1653, 2000 Lippincott Williams & Wilkins, Inc., Baltimore © International League Against Epilepsy Epilepsia Volume 41, 2000 Author Index Aberg LE, 1296 Beck H, 1249 Brodie MJ, 977 Abetz L, 1119 Beckerman B, 1269 Brodtkorb E, 529 Abou-Khalil B, 391 Beelke M, 201 Bromfield EB, 170 Abou-Khalil BW, 1187 Begemann M, 105 Brooks J, 98 Adamolekun B, 1044 Beghi E, 110 Brown MB, 1330 Adelson PD, 193 Begley CE, 342 Brown RJ, 1608 Aimi Y, 10 Behr J, 925 3rown S, 110 Airaksinen EM, 1214 Bell BD, 992 Bruce JN, 1463 Akata T, 909 Benardo LS, 1507 Buchhalter JR, 395 Al-Aweel IC, 536 Benbadis SR, 895 Buchheim K, 635 Aldenkamp AP, 1167 Ben-Menachem E, 1276 Buchner H, 71, 1574 Alenius M, 1289 Beran ME, 875 Buck D, 98 Alvarez LA, 1206 Beran RG, 875 Bulman DE, 132 Amarakone A, 1241 Berendschot TTJM, 581 Burgess DL, 24, 1074 Amark P, 308 Berg AT, 760, 1269 Burkhardt RT, 850 Andermann F, 113, 666, 825, 832 Bergin PS, 231 Burmeister M, 1046 Anhoury S, 1608 Burnham WM, 1400 Berkovic S, 529 Annegers JF, 342, 549 Burns L, 1540 Berkovic SF, 48, 463 Ansakorpi H, 42 Berlangieri SU, 463 Bussa B, 744 Antel SB, 832 Berry DJ, 624 Bye AME, 765, 1456 Anzivino MJ, 493 Berthele A, 818 Byun HS, 207 Arai N, 1489 Bertram E, 493 Armand V, 28 Bertram EH III, 502 Cairns DR, 765 Armitage LL, 1095 Besag FMC, 624 C alabrese G, 19 Arnold DL, 666, 825, 832 Bespalova IN, 1046 C amfield C, 1230 Arnold S, 818, 1153 Arpino C, 1436 Betts TA, 1420 C amfield P, 1230 Beyenburg S, 140 C ampbell BR, 332 Arrigo C, 868 Bialer M, 1107 C anizares S, 1303 Arroyo S, 1303 Bidlingmaier F, 140 C antello R, 694 Arunkumar G, 1474 Asconapé J, 479 Bielen E, 1179 C apurro D, 110 Bilir E, 963 C araballo R, 380 Ashizawa T, 24 Assal F, 687 BBiinndgearm aLnM , W,3 3297 1 ¢C aarrraamsacno osM arZi, na8 32,L L, 156170 05 Atzman O, 81 Binnie CD, 59, 1346 C ascino GD, 843 Austin JK, 615 Birbeck GL, 277 ( “assinello Garcia E, 1005 Avasthi G, 718 Avery RA, 1560 Birnbaum AK, 850 ¢ ‘astilla EE, 1436 Bjornes H, 91 C ‘avalli A, 694 Blanke O, 687 C “endes F, 666, 832 Babb T, 971 Bleasel A, 457 C “ereghino JJ, 868 Backman M, 1296 Bleasel AF, 765, 1456, 1540 C ‘espuglio R, 794 Baglietto MG, 201 Blom BH, 802 ¢ ‘hadwick D, 110, 1167 Bailet LL, 426 Blum AS, 536 C “*hadwick DW, 243 Baker G, 1167 Blum D, 1187 C ‘hang Y-C, 412 Baker GA, 98, 1119, 1357 Blum DE, 213 ( “hapouthier G, 651 Baker SA, 1616 Bliimcke I, 140, 1249 C ‘hen C, 1162 Bakker C, 19 Blustein JN, 895 C “hen Z-F, 493 Baldwin RA, 123 Boget T, 1303 C ‘heyette S, 862 Ball DE, 1044 Boleaga B, 158 C “hiarelli F, 1432 Balottin U, 1485 Bongiovanni LG, 1129 C “*hinvarun Y, 463 Barber C, 1420 Boon P, 440, 601 C “hung C-K, 1450 Barcs G, 1597 Borgatti R, 1485 ¢ ‘ian P, 222 Barnes PMF, 1420 Borowicz KK, 1112 C ‘ivardi C, 694 Barry JJ, 81 Bosco P, 19 C ‘lancy RR, 903 Bartenstein P, 818 Bouilleret V, 642 Clarke I, 48 Bartoli A, 222 Bourgeois BFD, 1057 Clayburn H, 502 Bast T, 1284 Bowling S, 963 Clear D, 243 Baudewig J, 71 Brans B, 601 Coan S, 342 Bauer J, 140 Brenner RP, 193 Coan SP, 549 Baumgartner C, 610, 1567 Brescianini S, 1436 Cocchi G, 1436 Baxendale SA, 231 Brigell MG, 148 Cohen JA, 148 Bazil CW, 760, 1463 Brito F, 158 Collins S, 1195 1650 AUTHOR INDEX Cook MJ, 1456, 1540 Ebner A, 564 Gonzalez-Hernandez T, 1259 Cooper P, 1167 Elger CE, 140, 186, 467, 811, 1249, 1597 Goodman RR, 1463 Corcoran ME, 1095 Elia M, 19 Greco R, 1432 Cornaggia CM, 110 Elices E, 1303 Greitz D, 290 Cornel MC, 1436 Elisevich K, 316, 1046 Gréppel G, 610 Corsi M, 1560 Elmquist J, 34 Gruenthal M, 240 Coughlin CT, 898 Emsley CL, 749 Grunze H, 1102 Cramer JA, 868 Ephraim T, 1522 Gudmundsson G, 1201 Crumrine PK, 193 Epilepsy Care Evaluation Group, 1014 Guénot M, 681 Cryer C, 1014 Erba G, 732 Giilgonen S, 405 Cunnane SC, 1400 Ergene E, 213 Gunter MJ, 1020 Czuczwar SJ, 1112, 1364 Eslinger PJ, 906 Guo N-W, 412 Eviatar L, 219 Guo Y-C, 1162 D’ Havé M, 601 Gupta AK, 718 D’Souza J, 1597 Fakhoury T, 391 Dahlin M, 308 Falter U, 1276 Haas-Lude K, 628 Dal Corso G, 967 Famulari M, 342 Hablitz JJ, 1082 Dammerman RS, 1080 Faradji H, 794 Hadam J, 971 Dani JA, 1063 Fattore C, 222 Halonen P, 1214 Data JL, 1187 Faught E, 963, 1342, 1546, 1626 Haltiner AM, 992 Davies KG, 992 Fazilat S$, 1227 Hamer HM, 554, 1039 De Boer H, 110 Fejerman N, 380 Handforth A, 1195 De Carli F, 201 Ferri R, 19 Hannesson DK, 1095 de Haan GJ, 1167 Ferrillo F, 201 Hara T, 1642 de LaCalle S, 34 Fiaschi A, 1129 Harding GPA, 1420 De Negri E, 201 Fiedler M, 516 Hardus P, 581 De Reuck J, 601 Fischer C, 681 Harnadek MCS, 1321 De Sarro GB, 19 Fish DR, 231 Hashimoto N, 1411 de Vasconcelos AP, 363 Fisher RS, 148 Haugvicova R, 1235, 1375 de Vigan C, 1436 Flesch G, 1597 Hauser A, 110 Dean P, 1206 Fodzo L, 432 Hauser WA, 549, 1201 Debilly G, 794 Foldvary N, 971 Hayakawa F, 714 Debus O, 588 Forgione M, 1463 Heck C, 1195 DeCarli C, 1227 Forsgren L, 1469 Heinemann U, 28, 635, 925 Deckers CLP, 1364 Fountain NB, 1534 Hekster YA, 1364 Deetha TD, 1027 Free SL, 352 Helms G, 290 DeGiorgio CM, 1195 Frey M, 1310 Henkel A, 818, 1153 Del Bigio MR, 655 Frick A, 1102 Hennessy MJ, 59 del Mar Pérez-Delgado M, 1259 Friedrich T, 1068 Henry T, 1195 Dell C, 1400 Frisén L, 1289 Henry TR, 316 DellaBadia J, 479 Fritz B, 1039 Herrendorf G, 71, 1574 Demirbilek V, 405 Frost FJ, 1020 Herzog AG, 34 Dennison H, 732 Frucht MM, 1534 Hesdon B, 1357 Derry PA, 177 Fuchs M, 1574 Hill MW, 1241 Dervent A, 405 Fujii T, 52 Hiramatsu M, 1091 Devinsky O, 400 Fujikawa DG, 981 Hirose S, 52 Dey H, 1560 Fujiwara T, 1584 Hirsch J, 400 Dickson WA, 453 Ho RT, 542 Diedrich A, 479 Gaillard WD, 1227 Hoch DB, i70 Dierckx R, 601 Gall CM, 493 Hoffman DA, 1072 Dodd RH, 651 Ganaxolone Presurgical Study Group, 1187 Holden L, 732 Doelman J, 1167 Garattini L, 110 Holmes GL, 34, 1051 Donati G, 1485 Garcia-Marin V, 1259 Homsma SJM, 110 Dongmo L, 432 Gassmann-Mayer C, 1167 Hoénack D, 1499 Doyle W, 400 Gatti G, 222 Hong K-S, 1450 Drislane FW, 536 Gauer LJ, 868 Hong SB, 207, 1554 Drury I, 316, 1330 Gause D, 1020 Hoppe M, 564 Drzezga A, 818 Geller E, 457 Hori A, 34 Dubeau F, 666, 825, 832 Gentsch K, 925 Hrachovy RA, 1078 Dubinsky S, 342 Geyer J, 1330 Huang C-C, 412 Duchowny MS, 1206 Gillespie GW, 1095 Hufnagel A, 467 Duhaime A-C, 903 Gilliam F, 963, 1474, 1546 Hughson C, 1167 Dumas M, 432 Gilliam FG, 1626 Huguenard JR, 1076 Diimpelmann M, 467 Gilman J, 1206 Huk WJ, 282 Duncan JS, 352 Gilmartin R, 1195 Hulsman J, 1167 Duncan R, 1167 Girvin JP, 1321 Hurley JS, 1020 Dunn DW, 615 Gizard F, 363 Huster GA, 615 Dunoyer C, 1206 Gobbelé R, 1574 Hyder F, 675 Dworetzky BA, 170 Goldberger AL, 536 Goldsmith IL, 395 Ikeda A, 1411 Eberhardt KWE, 282 Gondo K, 1642 Ikeda K, 1642 Ebers GC, 132 Gonzalez-Feria L, 1259 Inoue T, 1642 Ebert U, 372 Gonzalez-Gonzalez ML, 1259 Inoue Y, 1584 Epilepsia, Vol. 41, No. 12, 2000 AUTHOR INDEX Isnard J, 68] 1651 Isojarvi JIT, 42 Kotagal P, 457, 554, 971, 1474 IIttoa baMs,h i 52H H. 981 KKroazlgoewlsokhi- MaPn. n 655I , 628 LLoonngd onLo, 72A7. 1546 IIwvaest a JRH,, 55326 KKKrrriaaeumgssestr e iJnML ,, A1R95,59 07 1080 LL]o éossrsciihnuegs r DMWWI.,. 397]1 24,4 4 516, 1499 JJJJJJaaaaaaynlncclzanoko ucb nzhy DzaC ,inRP ,d,A 1r, G61 a.878n9 9748 3 2,. 2D 2.1 1] 31110952 7 KKKKKrrKuuriribbiussoiephhltspn nac a haRm EmIF,uo,, Cr o ,t1r 985h0t5119yh040 y 6 8 KBE,S , 53166 08 LLLLLiuooéihztwdatmeergnnaseotn n hn aH lOJA, . MH .J5.A 85, 86 1476,183 1177 997 ]. | 153 JJJJJJJoJoJoJooosienkeahbthnmeenysnyatseltan sns an ketcn eIakoJheBCz,rne V,sC n, s.T1 se 4PFJD1-,,5n,1.95 S 3 2 57c 11 111h124S5,0iI080 6,n7 6 828k 9e18]2. 8 9 A1,1 393 26 KKKKKKKKKwuKuuuuuuzuazurnnibnbnnblikoiuoio eek e evvdmaccaIaaaK Ck,k , nSyy P,n1 ,HTH 07 .,,11 4R R414GI2,3 1.,1]1 24 2 3]913655 6]54983 , 48, , 11315764526 6 MMMMMMMaMaMMaaaaararanalliheeegcdimhesshahosagr canzarrra raoreaPe utai ,Jnxt a ,K i RTL1T .A1,2. CKW,3 3 ,,P2.9 5 , 4 .16 ]9 45314 38|56233 931 18 2 ,329 79 5 6 42 Markand ON, 749 KaKKKKKKsKaKaKKaKaatapaaanananeninllnnkkagltsleeeduise aékkmre rainnaoo Da m yj tY-w n A,SoBHaW-S, M,, TtN,,P ., ,oa1 8 8 4Kl6n5552.46426sa 4] 3125 t1 2 0 3 1 1P00Ty3 r6e4 n5i7t é DGA. 1335 LLLLLLLLaaLaLaLaLaaaasuwaraPannnicngsdbgrbcgraaseifeeaasrooinyrsnrsoastnel t ntttc ruo eo h JD nrsMS ,-dJD ,CD MET R ,,J.,,PJ. | M T1,A ,192L|L76997 8, 316,515]19 440]9 3 |22 5 10 1 14 049234 6 MMMMMMMaMMaMaMaMaaataatatatarsisrrhhrerttrltcteerssiiarqihrjaonhnionuana n n ie eazVRRWnGc,PEG C, AoRo, , .wGn .vI R9.,z1,5 o5.6 4d 85 313l1848.625 e14 1P 21 8z32,363 1 59147051 M446.3 6 1005 KKKKKeeaaaltmwtlzaeoia snrway Tak ,yHi , A 7A1PJ14,,.3 9110001 433968, 2 1053 LLLLLeaaaaezxww aesnzrCo z Lne,Kr N ,,a J 1A011.M715 ,884 776 6 151,0 1456. 1540 MMMMMaaaaatuttttgssssuuuuoiuddnéraa ra eR YKHT,..,F ,9 21266549788 5 4} Key Ser A, 1364 Lee DA, 1187 May T, 564 Khan AA, 594 Lee DS, 65 Maytal J, 219, 959 Kifune A, 909 Lee D-S, 955 Mayville C, 39] KKiilkeuyc hiM A,S , 919693 3 LLeeee KKSH., 419434 4 MMcazAanraaltliy AML,. 1514203 KKiimm HB,G ,9 5655 LLeeee SS--HA., 925957 MMccCAaulbeey PHJ,W , 90764 4 Kim J-Y, 65. 1450 Lee SK, 65. 955, 1450 McGeer PL. 10 Kim K-w, 207 Lee W-o, 65 McInerney J, 57] KKKiiimmm SSS-E, K,, 7 62009 75.5 1554 LLLeeeihebnssetromtnaz CJ,K, . 534489121 MMMcccLLKaeicanhnnl oanJn, 1DR0.S4 .4 1 017302 , 177, 1321 Kimura H, 10 Lekvall A, 290 McMullen W. 400 King DW, 1444 Leppert M, 1066 McNulty P, 1119 KKKKKiiiiivttrriavaatde yyas a Rkm,aSa Kr,, i1 61M945,E422. ] 2 912299 6 LLLLLiheee awsvLtiayoMfs of, r SePR S,6, D6 E,61,. 11 9243568 4 93208 5 ,, 1853922 MMMMMeeeeeliilatneazdaremorkrerdo d ir CdKC JHS,... H .9 1110943633463 445 KKlleeiinnr oPk, 3Z4, |] 12 LLiik hXo-dLi,i 1S5S1.4 1400 MMeenndakoenrc a M.A , 50124 00 KKKKonnnbuuaatdkyssease sonhnS i , FEU1,K,0 ,3 39052 82 LLLLiiiinnnmd ddibiSne Sgr,eg NreA2 r.6 G 3, M 1,3 145261 72 89 MMMMeeeetrnnilk doeobBsz L a,P D, I1D 2.18 ,4 321643 09 0 Kogure §, 929 Lindsten H. 1469 Meyer FB, 843 KKoolhl e S,R , 12710,6 1574 LLiipotwa koKv,a 12S2, 7 788 MMiieclhkeel ucJc,i 10R4.4 967 Komatsu M. 109] Liu H-G, 594 Migliaretti G, 694 Kopylev L, 1227 Liu Z, 34 Mikati MA, 880 KKoorrpkemlaazin enB . J4T0,5 42 LLooigsee auJ H,P , 85| 179 MMiitkcuhneil l N,W G.14 1]1 616 Lombroso CT, 245. 122] Mitsudome A. 52 Mizrahi EM, 1049 Epilepsia, \ ol. 41, No. 12, 2000 1652 AUTHOR INDEX Mohamed A, 971 Ojha B, 594 Resnick TJ, 1206 Mohamed E, 1027 Okumura A, 714 Reynolds TF, 342 Mohapel P, 1095 Okuno T, 52 Rho JM, 862 Monaco F, 222, 694 Olafsson E, 1201 Rhodes HC, 1139 Monaghan EP, 1187 Olthof T, 326 Riaz H, 1167 Mononen T, 1214 Ong HT, 1474 Ridsdale L, 1014 Moore A, 1597 Oostra BA, 19 Riethmiiller J, 628 Moore JL, 727, 744 Oostrom KJ, 326 Riikonen R, 705 Moorjani BI, 457 Opeskin K, 48 Risinger MW, 320 Morawetz R, 963, 1546 Osorio I, 887, 1195 Ristanovic R, 1195 Morawetz RB, 1626 Ostrowsky K, 681 Roach J, 727 Morgese G, 1432 Overweg J, 1167 Robert E, 1436 Morrell MJ, 81, 320, 1187 Roberts DW, 571, 898, 1139 Morris GL, 1195 Pacia S, 400, 760 Robertson KA, 1420 Morris H, 971 Palmer CA, 1626 Rocca WA, 342 Morrison G, 1206 Pandian JD, 1027 Roh SY, 1554 Mosewich RK, 843 Park S-H, 1450 Rosano A, 1436 Moshé SL, 788 Park YD, 1444 Rose KJ, 177 Mott D, 744 Parra J, 1310 Rosenberg HJ, 447 Mountz JM, 594 Partanen J, 1214 Rosenberg SD, 447 Mueller RM, 332 Pascarella R, 1432 Rosenow F, 1039 Mulder OG, 1167 Passarelli D, 967 Ross DA, 316 Mulley J, 529 Pataraia E, 1567 Roéssler A-S, 651 Mundanda T, 1044 Patel M, 950 Rothman DL, 675 Mujfioz Hoyos A, 1005 Patsalos PN, 1364 Rothman SM, 1241 Murphy J, 1195 Pauli E, 282 Rousset C, 794 Murphy P, 862 Paulus W, 71, 1574 Rowan AJ, 105 Murro AM, 1444 Pavol M, 1321 Rumia J, 1303 Musa K, 1400 Peltzer JN, 887 Rundfeldt C, 28 Mustonen K, 1214 Pereira J, 1540 Rybicki L, 457 Musumeci SA, 19 Perrine K, 400 Ryvlin P, 681 Mykletun A, 802 Perucca E, 222, 1485 Myllyla VV, 42 Saab R, 880 Petersen HV, 1020 Sabaz M, 765 Na DG, 207 Petroff OAC, 675 Sachdev MS, 718 Nagelberg J, 950 Peyster RG, 148 Sadato A, 1411 Najm IM, 971 Pfander M, 1153 Salanova V, 749 Nakagawa E, 10 Piccinelli P, 1485 Salinsky M, 1195 Nam H-W, 1450 Pickering CT, 727 Salinsky MC, 332 Namer IJ, 642 Pitzalis S, 967 Salmanson E, 170 Narayanan V, 453 Pledger G, 1167 Sam MC, 1494 Naritoku DK, 1195 Pledger GW, 440 San Pedro EC, 594 Ndonko F, 432 Polizzi G, 1592 Sander JW, 1633 Negoro T, 714 Polkey CE, 1346 Sander JWAS, 338, 1592 Nehlig A, 363, 642 Pool F, 624 Sandok EK, 1315 Nei M, 542 Poolos NP, 1072 Santavuori P, 1296 Nergardh A, 308 Post RM, 1514 Santhoshkumar T, 1027 Neubauer BA, 1061 Postma G, 581 Sarma PS, 1027 Neuroimaging Subcommission of the Postma T, 1514 Savic I, 290 International League Against Epilepsy Prats A, 1206 Sawrie S, 1546 (ILAE), 1350 Preux P-M, 432 Sawrie SM, 1626 Newmark ME, 342 Prince DA, 1085 Scaramelli A, 1597 Newton MR, 463 Pulliainen V, 421 Schachter SC, 1195 Ney G, 1195 Schafer I, 282 Ngouafong P, 432 Qiao M, 655 Scheffer IE, $29, 1059 Nheu N, 765 Quigg M, 502, 1534 Scheier LM, 1616 Niemann G, 628 Scheuer ML, 193 Nikakhtar N, 1330 Racacho LJ, 132 Schiff DP, 193 Noachtar S, 818, 1153 Radhakrishnan K, 1027 Schijns O, 467 Nobile C, 967 Ragheb J, 1206 Schmitz B, 925 Nobili L, 201 Ramos Lizana J, 1005 Schober O, 588 Noda A, 941 Rancel-Torres N, 1259 Schomburg U, 1039 Noebels JL, 24, 1049, 1074 Ransil BJ, 34 Schomer DL, 536 Novak G, 219, 950 Raol YH, 128 Schottler F, 493 Nystrém L, 1469 Rating D, 1284 Schouten A, 326 Reed R, 1195 Schramm J, 140, 1249 O’Brien PC, 843 Reed RC, 887 Schroeder BC, 1068 O’Brien TJ, 843, 1315 Reeves AL, 727, 744 Schuchmann S, 635 O’Connor S, 601 Reissmiiller E, 372 Schuh LA, 316, 1330 Oda M, 1489 Remmel RP, 850 Schuierer G, 588 Oertel WH, 1039 Renier WO, 1364 Schulz R, 564 Ohara S, 1411 Rentmeester TW, 1167 Schulze-Bonhage A, 186 Ohman I, 709 Renzi C, 1436 Schumacher TB, 1249 Epilepsia, Vol. 41, No. 12, 2000 AUTHOR INDEX 1653 Schwaner C, 1534 Su M-S, 1162 Vigevano F, 482 Schwartz TH, 1463 Suchomelova L, 1375 Vitols S, 709 Schwarz P, 781 Sumiyoshi Y, 1436 Vogrin S, 1456, 1540 Seibyl JP, 1560 Sun L, 263 Voigt B, 941 Selwa LM, 1330 Sunstad L, 895 Volosov A, 1107 Seo DW, 207, 1554 Suominen K, 42 Vonck K, 601 Serikawa T, 941 Swann JW, 1078 Vuilleumier P, 687 Serles W, 1567 Swinkels WAM, 1335 Seshia SS, 655 Sze G, 148 Waaler PE, 802 Seyfried TN, 933 Waberski TD, 71, 1574 Shackleton DP, 1335 Taki W, 1411 Wagner AK, 170 Shanahan CW, 170 Tamir A, 1522 Wakat J-P, 1039 Sharbrough FW, 843 Tanaka M, 1584 Walczak TS, 760 Sharpe JA, 1637 Tandon P, 933 Walden J, 1102 Shatz R, 1046 Tarletti R, 694 Walker EB, 1597 Shibasaki H, 1411 Tassi L, 482 Walters GL, 992 Shibata N, 909 Tassinari CA, 967 Wang S-T, 412 Shih JJ, 213 Taylor RB, 1637 Wasterain CG, 123 Shimada M, 10 Tecoma E, 1195 Watanabe K, 714 Shimizu H, 1489 Tenembaum SN, 380 Watanabe Y, 1584 Shinmei SS, 981 Testa FM, 1269 Watzka M, 140 Shinnar S, 760, 1269 Thadani VM, 571, 898, 1139 Weckesser M, 588 Shorvon SD, 231, 1179 The RESt-1 Group, 998 Weis S, 818 Siegel AM, 571, 1139 Theodore WH, 1227 Weiss SRB, 1514 Siegmund H, 635 Thomas J, 963 Weissinger F, 635 Sillanpaéaé M, 110 Thomas SV, 1027 Weitz R, 1522 Sills GJ, 977 Thompson J, 1195 Wennberg RA, 1637 Silveira DC, 34 Thompson PJ, 231 Werhahn KJ, 818, 1153 Singh G, 718 Thorbecke R, 110 Wheless J, 1195 Sisodiya SM, 352 Tiemagni F, 432 Whelihan E, 749 Skeidsvoll H, 802 Tirath A, 718 Whiting SE, 1206 Skutova M, 1235, 1375 Todorova MT, 933 Wide K, 854 Smith B, 1046 Tofani A, 1485 Widman G, 811 Smith BJ, 316 Tolle TR, 818 Wild JM, 1420 Smith JW, 1444 Tolonen U, 42 Williamson PD, 447, 571, 898, 1139 Smith KL, 1078 Tomandl B, 282 Willmore LJ, 1091 Smith SJM, 1633 Tomson T, 709, 854, 1289 Winbladh B, 854 Smith-Rapaport S, 1269 Tooyama I, 10 Winkler PA, 818, 1153 So EL, 342, 843, 1315, 1494 Torres X. 1303 Wolf C, 1284 So NK, 213 Tortorelli S, 201 Wolff M, 628 Sofia RD, 123 Townes BD, 405 Wolford GL II, 447 Song Hc, 65 Townsend DW, 193 Wolgamuth B, 554 Sonnen AEH, 110 Trimble MR, 1608 Wong ICK, 338, 1592 Sotero de Menezes MA, 862 Tsai J-J, 412 Wong M, 271, 1241 Spanaki MV, 1227 Tuhrim S, 105 Woolley CS, 510 Spencer DC, 320 Tuor UI, 655 Wroe S, 1167 Spencer DD, 297 Turk WR, 426 Wu A, 981 Spencer SS, 297, 760, 1560 Tuxhorn I, 564 Wyllie E, 554, 971, 1474 Sperling MR, 542, 760 Stafstrom CE, 933 Urbach H, 811 Yagen B, 1107 Stanford L, 554 Uthman B, 1195 Yagi K, 1584 Stavem K, 85, 91 Yagishita A, 1489 Steele R, 219 Van Cott A, 193 Yamada K, 1584 Stefan H, 282, 1597 Van Hammée G, 868 Yamada KA, 271 Steffens R, 1249 Van Laere K, 601 Yamazoe H, 941 Stein V, 1068 Van Rijn CM, 1364 Yang L, 1507 Steinhauser C, 1249 van Veelen CWM, 581 Yasuhara O, 10 Steinhoff BJ, 71, 1574 Vandekerckhove T, 601 Yen D-J, 1162 Steinlein OK, 529 Vanhatalo S, 705 Ying Z, 971 Stephen LJ, 977 Varrasi C, 694 Yiu C-H, 1162 Stevens JM, 352 Vaughn B, 1195 Yousry TA, 818 Stichel CC, 781 Vazquez Lopez M, 1005 Yu H-Y, 1162 Stilma JS, 581 Velasco AL, 158 Stoffel-Wagner B, 140 Velasco F, 158 Zagon A, 1382 Stokking R, 1560 Velasco M, 158 Zampino G, 1436 Stoodt J, 529 VeliSek L, 788 Zanette G, 1129 Storzbach D, 332 VeliSkova J, 788 Zentner J, 467 Straume M, 502 Venault P, 651 Zhou X-Y, 1102 Studholme C, 1560 Verduin WM, 581 Ziegler RG, 732 Sturm JW, 463 Vergnes M, 794 Zis FY, 913 Sturm K, 1039 Verrotti A, 1432 Zubal IG, 1560 Sturm Y, 1597 Vickrey BG, 760 Zupanc ML, 395 Epilepsia, Vol. 41, No. 12, 2000 Epilepsia, 41(12):1654—1668, 2000 ums & Wilkins, Inc., Baltimore Internati League Against Epilepsy Epilepsia Vol. 41, 2000 Subject Index Absence seizures. See Seizures. unsuccessful testing in preadolescent children, 554 Absorption in Wada test, contralateral EEG slowing, 207 rectal, of lamotrigine compressed tablets, 850 Amygdala kindling Abuse claustral lesions, 1095 trauma and posttraumatic stress disorder, in seizure patients, 447 lamotrigine effect on seizures, 1514 Accident prevention levetiracetam tolerance, 1499 burn treatment, in epilepsy, 453 7-nitroindazole effects on antiepileptic drugs, 1112 psychogenic nonepileptic seizures, 895 repeated acute testing of anticonvulsant drugs, 516 social factors of epilepsy, in Europe, 998 Aneurysm N-Acetyl aspartate (NAA) subarachnoid hemorrhage, risk of epilepsy, 1201 frontal lobe, juvenile myoclonic epilepsy, 290 Animal studies in newly diagnosed partial epilepsy, MR spectroscopy, 825 antiepileptic drug polytherapy, mechanisms of action, 1364 Acidosis dog, 10-hydroxycarbazepine enantiomers, comparative pharmaco- renal tubular, with zonisamide therapy, 1642 kinetics, 1107 Adherence guinea pig, hippocampus, lamotrigine effects on field potentials to treatment, childhood epilepsy, 1616 and Adolescents long-term potentiation, 1102 psychosocial and neurologic care of children with seizures, 732 mouse, audiogenic seizures, fragile X syndrome, 19 Adverse effects mouse, benzodiazepine binding in subkindling, 651 epilepsy-related quality of life, levetiracetam effects, 868 mouse, epileptogenesis inhibited by ketogenic diet, 933 frontal nonconvulsive status epilepticus with tiagabine therapy, mouse, hippocampal MRI in mesial temporal lobe epilepsy, 642 familial bilateral perisylvian polymicrogyria, 1485 mouse, hippocampal-entorhinal slices, cooling effects on seizures, intracranial electrodes, 898 1241 lamotrigine-induced tic disorder, in children, 862 rabbit, simultaneous kindling of bilateral hippocampi, epilepsy nystagmus, and deep brain stimulation, in epilepsy, 1637 model, 929 phenobarbital and primidone cross-tolerance, 1310 rat, amygdala kindling, 7-nitroindazole effects on antiepileptic renal tubular acidosis, with zonisamide therapy, 1642 drugs, 1112 topiramate, in refractory epilepsy, 977 rat, amygdala kindling, vigabatrin effects on sleep, 128 topiramate, in refractory partial epilepsy, 1162 rat, anticonvulsant drug testing in amygdala kindling, 516 topiramate vs. valproate add-on therapy to carbamazepine, cogni- rat, brain, zonisamide reduction of 8-OHdG during epileptogen- tive esis, 1091 function in partial-onset seizures, 1167 rat, claustrum, amygdaloid kindling, 1095 vagus nerve stimulation, refractory seizures, 1195 vagus nerve stimulation, tonsillar pain, 903 rat, cortical neurons, vagus nerve stimulation, slow hyperpolariza- tion, 1382 valproic acid-induced hyperammonemic encephalopathy, with tri- rat, cyclosporine induction of epileptiform activity, 271 phasic waves, 909 rat, developing, anticonvulsant actions of tiagabine, 1375 vigabatrin-induced visual field constriction, 1420 rat, developing, ganaxolone effect on flurothyl seizures, 788 Affective disorder rat, developing, topiramate effect on motor seizures, 1235 after temporal lobectomy, 1608 rat, entorhinal cortex, low magnesium-induced seizures, fenflur- Age factors amine effects, 925 childhood epilepsy, 802 rat, estrogen effect on kainic acid seizures, 510 nitric oxide role in pentylenetetrazol seizures, 363 rat, felbamate effects on status epilepticus, 123 psychosocial and neurologic care of children with seizures, 732 rat, GAERS model, nitric oxide role in sleep and epilepsy, 794 Amino acids rat, hippocampal sclerosis, theophylline and trimethobenzamide CHRNAG4 Ser248Phe mutation, nocturnal frontal lobe epilepsy, effects, 1390 529 rat, ketogenic diet, dietary fat, ketosis, and seizure resistance, valproic acid-induced hyperammonemic encephalopathy, with tri- 1400 phasic rat, lamotrigine during amygdala-kindled seizures, 1514 waves, 909 rat, lateral symmetry with unilateral amygdaloid seizures, 34 y-Aminobutyric acid. See GABA y-aminobuiyric acid). rat, levetiracetam tolerance, amygdala kindling, 1499 4-Aminopyridine rat, limbic epilepsy, circadian regulation of seizures, 502 seizures, optical signals, 635 rat, NER strain, tonic-clonic seizures, chromosomal mapping for Amnesia epilepsy genes, 941 after temporal lobectomy, intracarotid amobarbital procedure, 1321 rat, neuronal migration disorders in neocortical structures, 781 Amobarbital rat, nitric oxide role in pentylenetetrazol seizures, age effects, 363 intracarotid, cognitive function after ATL, 922 rat, optical signals in low Mg?*- and 4-aminopyridine-induced intracarotid, global amnesia after temporal lobectomy, 1321 seizures, 635 lateralization of seizure focus, 65 rat, progenitor cell division in dentate gyrus, induction by limbic patient evaluation for epilepsy surgery, 320 seizures, 10 SUBJECT INDEX 1655 rat, retigabine in magnesium-induced epileptiform activity in ento- neurocognitive, in childhood epilepsy, 426 rhinal cortex hippocampus, 28 vigabatrin long-term effects, developing brain, 655 rat, SGB-017 blockage of voltage-gated sodium channels, vs. car- Benzodiazepine bamazepine, 263 binding in subkindling, 651 rat, subcortical band heterotopia, seizure activity, 493 receptor binding, seizure onset zone in extratemporal focal cortical rat, topiramate in kindling model, 372 dysplasia, 818 rat, valproate prevention of epilepsy, after neocortical trauma, Bioavailability 1507 lamotrigine compressed tablets, rectal absorption of, 850 rat, vigabatrin long-term effects on immature brain, 655 Body dimensions Anterior temporal lobectomy (ATL) fetal growth, exposure to antiepileptic drugs in utero, 854 intracarotid amobarbital, and cognitive function, 922 Bone Antiepileptic drugs See also specific agents. cortical dysplasia with ossification, 1489 availability in Cameroon, 432 Book Reviews benign focal childhood epilepsy, 1057 The Brainstorms Woman: Epilepsy in Our Lives, 484 costs of epilepsy treatment, 342 Dysplasia of Cerebral Cortex and Epilepsy, 484, 776 epilepsy and juvenile neuronal ceroid lipofuscinosis, 1296 The Epilepsies. Etiologies and Prevention, 256 metabolic changes in bifrontal epilepsy, 588 Epilepsy: The Comprehensive CD-ROM, 775 7-nitroindazole effects, in amygdala kindling, 1112 Epilepsy, The Indian Perspective, 484 number-needed-to-treat method, in trials, 440 Essentials of Clinical Epilepsy, Second Edition, 255 polytherapy, mechanisms of action, 1364 Fast Facts: Epilepsy, 486 quality of life and behavior outcome, methodology and reporting Genetics of Focal Epilepsies, 254 standards, 1357 Goldensohn’s EEG Interpretation: Problems of Overreading and quality of life measurement, in children, 765 Underreading, 2nd Completely Revised Edition, 254 referral patterns of primary care physicians, 744 Magnetic Resonance Spectroscopy Diagnosis of Neurological Dis- renal tubular function, 1432 eases, 776 repeated acute testing in amygdala kindling, 516 Medically Refractory Epilepsy, 1645 teratogenesis, 1436 The Practice of Neurosurgery, 775 therapeutic drug monitoring, newly diagnosed epilepsy, 222 A Textbook of SPECT in Neurology and Psychiatry, tN anN n trials in private clinical practice, 875 Brain in utero, fetal growth, 854 cerebral and cerebellar volume reduction, childhood epilepsy, vigabatrin-induced intramyelinic edema, 148 1456 Aphasia cortical dysplasia with ossification, 1489 BCECTS, atypical evolution, 380 CT, emergency evaluation of children with seizures, 950 familial, variant of partial epilepsy, 1036 development, intrinsic circuits, 1082 Landau-Kleffner syndrome, immunoglobulin monotherapy, 880 development, neurotransmitter actions, 1080 Apnea entorhinal cortex, low magnesium-induced seizures, fenfluramine postictal central, SUDEP, 1494 effects, 925 Arachnoid cyst GABA, homocarnosine, and pyrrolidinone, gabapentin effects, 675 seizures in head injury, 243 immature, vigabatrin long-term effects, 655 Arrhythmias metabolism, ictal FDG PET, of extratemporal epileptic foci, 193 interictal cardiovascular autonomic responses, temporal lobe epi- metabolism and perfusion, uncoupling of, PET and SPECT ratio- lepsy, 42 images, 1560 partial seizures in refractory epilepsy, 542 neocortical, neuronal migration disorders, 781] Asthma subcortical band heterotopia, seizure activity, 493 and childhood epilepsy, gender and behavior problems, 615 volume reduction, predictors of, in childhood epilepsy, 1456, 1540 Ataxia, spinocerebellar zonisamide reduction of 8-OHdG during epileptogenesis, 1091] calcium channel gene CACNG2 localization, 24 Breast milk Attention lamotrigine pharmacokinetics, 709 neurocognition and behavior, febrile convulsions, 412 Burns Audiogenic seizures in epilepsy patients, 453 fragile X syndrome, 19 Byzantine medicine Auditory system epilepsy of Emperor Michael IV, Paphlagon, accounts of histori- autosomal dominant partial epilepsy, 967 ans and physicians, 913 Auras frontal lobe epilepsy, intractable seizures, 1139 Calbindin Automatism in inhibitory interneurons, neuronal migration disorders, 781 frontal lobe epilepsy, intractable seizures, 1139 Calcification Autonomic nervous system focal cortical-subcortical, and epilepsy, 718 cardiopulmonary instability, oxygen desaturation in partial sei- Calcium channels zures, 536 in dentate gyrus neurons, modulation by glutamate receptors, tem- interictal cardiovascular responses, temporal lobe epilepsy, 42 poral lobe epilepsy, 1249 in inherited generalized epilepsy, 1074 Carbamazepine BCECTS (benign localization-related epilepsy in children) and fetal growth, exposure in utero, 854 atypical evolution, 380 and phenytoin, in refractory idiopathic absence status epilepticus, 887 Behavior renal tubular function, 1432 adherence to treatment, childhood epilepsy, 1616 repeated acute testing, amygdala kindling, 516 and antiepileptic drugs, methodology and reporting standards, vs. SGB-017 (ADCI) blockage of voltage-gated sodium channels, 1357 263 childhood epilepsy and asthma, gender role, 615 topiramate vs. valproate add-on therapy, cognitive function in estrogen effect on kainic acid seizures, 510 partial-onset seizures, 1167 and loss of consciousness in absence seizures, 687 Cardiovascular system neurocognition, febrile convulsions, 412 interictal autonomic responses, temporal lobe epilepsy, 42 Epilepsia, Vol. 41, No. 12, 2000 1656 SUBJECT INDEX Cavernous sinus mapping for epilepsy genes, tonic-clonic seizures, 941 EEG, seizures on mesial temporal lobe epilepsy, 1411 18q- deletion syndrome, autonomic seizures vs. syncope, 1039 Cell death Cingulate gyrus epilepsy in status epilepticus, without epilepsy, 981 SPECT localization of seizures, 594 Cerebellum Circadian rhythm atrophy, in temporal lobe epilepsy, 1315 seizure regulation, limbic epilepsy, 502 volume reduction, in childhood epilepsy, 1456 Classification volume reduction, predictors of, in childhood epilepsy, 1540 cerebral and cerebellar volume reduction, in childhood epilepsy, Cerebral cortex 1456 nitric oxide synthase, in epilepsy, 1259 childhood epilepsy, 802 Cerebrospinal fluid (CSF) epilepsy diagnosis, reassessment after 2 years, 1269 nitrate/nitrite, in PEHO syndrome, 705 occipital paroxysms, childhood epilepsy, 1522 Chemotherapy Claustrum and intracranial electrode complications, 898 lesions, and amygdaloid kindling, 1095 Children and infants Clinic attendance atypical evolution in BCECTS, 380 leader education, 1044 benign familial neonatal convulsions, potassium channel genes, Clinical studies 1066 absence seizures, behavioral and EEG topographic correlates of benign focal epilepsy, clinical spectrum, 1051 loss of consciousness, 687 benign focal epilepsy, drug treatment, 1057 absence seizures, tonic-clonic activity, 391 benign focal epilepsy, genetically determined pathophysiology, acute seizures, rapid intravenous loading of valproate, 1342 1085 amnesia after temporal lobectomy, intracarotid amobarbital proce- benign focal epilepsy, workshop report, 1049 dure, 1321 brain CT, emergency evaluation of seizures, 950 amobarbital, patient evaluation for surgery, 320 clonazepam effects, 308 anterior cingulate gyrus epilepsy, SPECT localization, 594 diagnosis of epilepsy, first seizures, 1230 anticonvulsant therapy, and renal tubular function, 1432 drug-induced metabolic changes in bifrontal epilepsy, 588 antiepileptic drugs, quality of life and behavior outcome, method- early postictal EEG, complex febrile seizures, 219 ology and reporting standards, 1357 epilepsy, adherence to treatment, 1616 antiepileptic therapy in Cameroon, 432 epilepsy, and asthma, gender and behavior problems, 615 asymmetric tonic limb posturing, in tonic-clonic seizures, 457 epilepsy, and neurocognitive behavior, 426 atypical evolution in BCECTS, 380 epilepsy, cerebral and cerebellar volume reduction, 1456 autonomic dysfunction in temporal lobe epilepsy, 42 epilepsy diagnosis, reassessment after 2 years, 1269 autonomic seizures, vs. syncope, in 18q- deletion syndrome, 1039 epilepsy, and juvenile neuronal ceroid lipofuscinosis, antiepileptic autosomal dominant nocturnal frontal lobe epilepsy, 52 drug therapy, 1296 autosomal dominant partial epilepsy, auditory features, 967 epilepsy and mental retardation, 1214 bitemporal independent interictal epileptiform discharges, in tem- epilepsy, occipital paroxysms, 1522 poral lobe epilepsy, 213 epilepsy, predictors of hippocampal, cerebral, and cerebellar vol- burns and epilepsy, 453 ume reduction, 1540 calcification, focal cortical-subcortical, and epilepsy, 718 epilepsy, prevalence, classification, and severity, 802 cavernous sinus EEG, seizures on mesial temporal lobe epilepsy, epilepsy, quality of life, parent- and patient-validated content, 1411 1474 cerebellar atrophy, in temporal lobe epilepsy, 1315 exposure to antiepileptic drugs in utero, fetal growth, 854 chemical shift imaging spectroscopy, and memory function in juvenile myoclonic epilepsy, frontal lobe N-acetylaspartate, 290 temporal lobe epilepsy, 282 juvenile myoclonic epilepsy, intracortical inhibition, 1129 childhood epilepsy and asthma, gender and behavior problems lamotrigine-induced tic disorder, 862 615 Landau-Kleffner syndrome, immunoglobulin monotherapy, 880 childhood epilepsy, cerebral and cerebellar volume reduction, neonatal epilepsy and progressive deafness, KCNQ channels, 1068 1456 neurocognition and behavior, febrile convulsions, 412 childhood epilepsy, occipital paroxysms, 1522 occipital lobe epilepsy, neuropsychological factors, 405 childhood epilepsy, prevalence, classification, and severity, 802 partial epilepsy, early recognition, 714 clonazepam effects in children, 308 pavor nocturnus, epileptic origin, 1221 cluster analysis, semiology of nonepileptic seizures, 610 PEHO syndrome, CSF nitrate/nitrite, 705 cognitive function, topiramate vs. valproate as add-on therapy to perinatal head injury, cortical dysplasia, 245 carbamazepine, partial-onset seizures, 1167 preadolescent, unsuccessful amobarbital testing, 554 congenital bilateral perisylvian syndrome, epileptogenesis, 1584 quality of life measurement, 765 contralateral EEG slowing and amobarbital, in Wada test, 207 rolandic epilepsy, genetics of, 1061 contralateral secondary seizures, temporal lobe epilepsy, 1444 seizure recurrence, 1005 cortical dysplasia, early postnatal closed head injury, 245 seizures in rural Zambia, 277 cortical excitability, in cryptogenic localization-related epilepsy, shame and guilt, in epilepsy, 326 694 Status epilepticus, frontal nonconvulsive, tiagabine therapy in fa- cortical language distribution, cognitive function, 400 milial bilateral perisylvian polymicrogyria, 1485 diagnosis of epilepsy, first seizures, 1230 sulthiame monotherapy, benign childhood epilepsy with centro- dipole-source analysis, head model of focal epilepsy, 71 temporal spikes, 1284 drug-induced metabolic changes in bifrontal epilepsy, 588 teratogenic effects of antiepileptic drugs, 1436 early postictal EEG in children with complex febrile seizures, 219 tuberous sclerosis complex, presurgical evaluation, 1206 electrodes, intracranial, after failed invasive monitoring, 571 vigabatrin-associated encephalopathy, 628 emergency evaluation of seizures, brain CT in children, 950 CHRNA4 Ser248Phe mutation epilepsy after aneurysmal subarachnoid hemorrhage, 1201 nocturnal frontal lobe epilepsy, 529 epilepsy cost, 342 Chromosomes epilepsy diagnosis, reassessment after 2 years, 1269 autosomal dominant partial epilepsy, auditory features, 967 epilepsy and juvenile neuronal ceroid lipofuscinosis, antiepileptic chromosome 22q13, calcium channel gene CACNG2 localization, drug therapy, 1296 24 epilepsy and neurocognitive behavior, 426 Epilepsia, Vol. 41, No. 12, 2000 SUBJECT INDEX 1657 epilepsy-related quality of life, levetiracetam effects, 868 psychosocial and neurologic care of children with seizures, 732 epileptiform discharges in sleep, Landau-Kleffner syndrome, 201 psychosocial factors, epileptic seizures, WPSI study, 1335 extratemporal focal epilepsy, benzodiazepine receptor binding, Quality of Life in Epilepsy Inventory, Norwegian version, 91 seizure onset zone, 818 quality of life measurement in children, 765 familial aphasia, variant of partial epilepsy, 1036 reactive post-resection spikes, 1463 fetal growth, antiepileptic exposure in utero, 854 rectal absorption of lamotrigine compressed tablets, 850 flumazenil-induced partial epileptic seizures, 186 referral patterns of primary care physicians, 744 focal cortical dysplasia, transcranial magnetic stimulation, 240 refractory complex-partial status epilepticus, propofol treatment, frontal lobe epilepsy, intractable seizures, 1139 105 frontal lobe epilepsy, prediction of surgical outcome, 843 refractory epilepsy, quality of life, 749 functional mapping of insular cortex, 681 refractory epilepsy, seizure severity and quality of life, 760 gabapentin effects on brain GABA, homocarnosine, and pyrrolidi- remote memory in epilepsy, 231 none, 675 renal tubular acidosis, with zonisamide therapy, 1642 ganaxolone, anticonvulsant activity, 1187 SAHCS, and temporal lobe seizures and paroxysmal EEG, 158 genetic heterogeneity for febrile convulsions, 132 seizure precipitants, in epilepsy syndromes, 1534 health status in epilepsy, 85 seizure recurrence, in children, 1005 heterotopia, in refractory epilepsy, 352 seizures, head injury, 243 hypnotic seizure induction, 81 seizures in rural Zambia, 277 ictal FDG PET of extratemporal epileptic foci, 193 shame and guilt, in childhood epilepsy, 326 ictal SPECT, in temporal lobe epilepsy, 955 single seizure, effects on health status and health care utilization, ictal spiking, temporal depth electrodes, 316 170 ictal surface EEG and seizure semiology, lateralization in temporal source reconstruction, mesial temporal epileptiform activity, 1574 lobe epilepsy, 1567 spatiai distribution of neuronal complexity loss, in neocortical le- idiopathic generalized epilepsy, hemiconvulsive seizures, 1633 sional epilepsy, 811 immunoglobulin monotherapy in Landau-Kleffner syndrome, 880 status epilepticus, frontal nonconvulsive, tiagabine therapy in fa- intracarotid amobarbital, cognitive function after ATL, 922 milial bilateral perisylvian polymicrogyria, 1485 intracranial EEG seizure-onset patterns, neocortical epilepsy, 297 status epilepticus, refractory idiopathic absence, phenytoin and intracranial interictal spike activity, epilepsy surgery, 467 carbamazepine effects, 887 juvenile myoclonic epilepsy, intracortical inhibition, 1129 status epilepticus without epilepsy, neuronal loss, 981 lamotrigine, gabapentin, and topiramate retention rates, in epi- stigma of epilepsy, 98 lepsy, 1592 sudden death in epilepsy, prolactin levels, 48 lamotrigine pharmacokinetics, in pregnancy, 709 sulthiame monotherapy, benign childhood epilepsy with centro- lamotrigine-induced tic disorder, in children, 862 temporal spikes, 1284 Lennox—Gastaut syndrome, seizure outcome, MRI head imaging, surgical outcome in mesial TLE, and ictal scalp EEG propagation, 395 564 levetiracetam as add-on therapy, refractory partial seizures, 1179 temporal lobe epilepsy, 5a-reductase and 3a-hydroxysteroid levetiracetam tolerance, refractory partial seizures, 1276 oxidoreductase in hippocampus, 140 magnetic resonance spectroscopy, lateralization in temporal lobe temporal lobe epilepsy, MRI, mesial temporal sclerosis, surgical epilepsy, 832 outcome, 963 myoclonus, and gabapentin use, 479 temporal lobe epilepsy, preoperative emotional adjustment, and negative mood, and cognitive function, 421 postoperative depression, 177 neocortical epilepsy, ictal surface EEG, 1450 temporal lobe epilepsy, Wisconsin Card Sorting Performance, neocortical lesional epilepsy, spatial distribution of neuronal com- 1626 plexity loss, 811 teratogenic effects of antiepileptic drugs, 1436 neurocognition and behavior, febrile convulsions, 412 therapeutic drug monitoring in newly diagnosed epilepsy, 222 neuronal metabolic dysfunction in partial epilepsy, MR spectros- tonic seizures, lateralization in focal epilepsy, 1153 copy, 666 topiramate, in chronic epilepsy, 338 neuroticism after epilepsy surgery, 1303 topiramate, in refractory epilepsy, 977 newly diagnosed unprovoked epilepsy, mortality risk, 1469 topiramate, in refractory partial epilepsy, 1162 nitric oxide synthase, in cerebral cortex in epilepsy, 1259 trauma and posttraumatic stress disorder, in seizure patients, 447 NMDA receptor subunit NR2A/B, and epileptogenesis in cortical tuberous sclerosis complex, presurgical evaluation in children, dysplasia, 971 1206 nonepileptic seizures, MMPI and EEG measures, 332 vagus nerve stimulation, in refractory epilepsy, 601 nonepileptic seizures, outcome factors, 1330 vagus nerve stimulation, refractory seizures, 1195 number-needed-to-treat method, in drug trials, 440 vagus nerve stimulation, tonsillar pain, 903 nystagmus induced by deep brain stimulation, in epilepsy, 1637 valproic acid-induced hyperammonemic encephalopathy with tri- occipital lobe epilepsy, ictal SPECT and interictal PET, 463 phasic waves, 909 occipital lobe epilepsy, neuropsychological factors, 405 vigabatrin vs. gabapentin, add-on therapy in partial seizures, 1289 occipitoparietal epilepsy, hippocampal atrophy, congenital devel- vigabatrin-associated encephalopathy, 628 opmental abnormalities, 1546 vigabatrin-induced intramyelinic edema, 148 oxcarbazepine, in refractory partial epilepsy, 1597 visual field, vigabatrin-induced constriction, electro-oculography, partial epilepsy, in infants, early recognition, 714 electroretinography, visual evoked potentials, 1420 partial epilepsy, newly diagnosed, MR spectroscopy, 825 visual field contraction, temporal lobe epilepsy, and vigabatrin patient knowledge of epilepsy, 727 medication, 58] patient-based assessment of NEWQOL, newly diagnosed epilepsy, Wada memory test, and temporal lobe glucose metabolism, 1554 1119 Wada memory test, lateralization of seizure focus, 65 PEHO syndrome, in children, CSF nitrate/nitrite, 705 Wada test, topiramate effects, 906 PET and SPECT ratio-images, uncoupling of brain metabolism Clonazepam and perfusion, 1560 in children with epilepsy, 308 phenobarbital and primidone, cross-tolerance, 1310 Cognitive function photogenic partial seizures, 59 and behavior, childhood epilepsy, 426 progressive myoclonus epilepsy, vagus nerve stimulation, 1046 cortical language distribution, 400 psychiatric outcome after lobectomy, 1608 intracarotid amobarbital after ATL, 922 Epilepsia, Vol. 41, No. 12, 2000 1658 SUBJECT INDEX Lennox—Gastaut syndrome, seizure outcome, MRI head imaging, Developing countries 395 antiepileptic drug availability in Cameroon, 432 and negative mood in epilepsy, 421 epilepsy, and focal cortical-subcortical calcification, 718 neuroticism after epilepsy surgery, 1303 India, prevalence, knowledge, attitude, and practice of epilepsy, topiramate vs. valproate as add-on therapy to carbamazepine, 1027 partial-onset seizures, 1167 seizures in rural Zambia, 277 Compliance Zimbabwe, leader education, clinic attendance, 1044 childhood epilepsy, adherence to treatment, 1616 Development patient knowledge of epilepsy, 727 anticonvulsant actions of tiagabine, 1375 psychosocial and neurologic care of children with seizures, 732 brain, vigabatrin long-term effects, 655 Computed tomography (CT) congenital abnormalities, occipitoparietal epilepsy, 1546 brain, emergency evaluation of children with seizures, 950 ganaxolone effect on flurothyl seizures, 788 epilepsy, and focal cortical-subcortical calcification, 718 neocortex, intrinsic circuits, 1082 intracranial interictal activity, presurgical epilepsy, 467 neocortical, neurotransmitter actions, 1080 Computer monitors. photogenic partial seizures, 59 neuroplasticity and epilepsy, 1078 Concussion nitric oxide role in pentylenetetrazol-induced seizures, age factors, seizures, 243 363 Congenital syndromes. See Genetic factors. teratogenic effects of antiepileptic drugs, 1436 Consciousness, loss of topiramate effect on motor seizures, 1235 absence seizures, behavioral and EEG topographic correiates, 687 Diagnosis Convulsions epilepsy, first seizures, 1230 benign familial neonatal, potassium channel genes, 1066 epilepsy, reassessment after 2 years, 1269 blows to head, 243 ILAE commission report on diagnostic strategies, functional neu- febrile, cognition and behavior, 412 roimaging in epilepsy, 1350 febrile, genetic heterogeneity, 132 Diaschisis Cortical dysplasia cerebellar atrophy, in temporal lobe epilepsy, 1315 NMDA receptor subunit NR2A/B, and epileptogenesis, 971 Diazepam perinatal head injury, 245 for febrile seizures, 2 subcortical band heterotopia, seizure activity, 493 Diet transcranial magnetic stimulation, 240 ketogenic, seizure resistance, 1400 Cost effectiveness Dipole-source analysis epilepsy treatment, 342 head model of focal epilepsy, 71 Counseling DNA patient knowledge of epilepsy, 727 autosomal dominant nocturnal frontal lobe epilepsy, 52 Cyclosporine fragmentation, progenitor cell division in dentate gyrus, induction induction of epileptiform activity, 271 by Cysticercosis limbic seizures, 10 epilepsy, and focal cortical-subcortical calcification, 718 Driving issues patient knowledge of epilepsy, 727 Database psychogenic nonepileptic seizures, 895 teratogenic effects of antiepileptic drugs, 1436 social factors of epilepsy, in Europe, 998 Deafness Drug interactions neonatal epilepsy, KCNQ channels, 1068 methsuximide effects on lamotrigine, 624 Death, sudden phenobarbital and primidone, cross-tolerance, 1310 oxygen desaturation and partial seizures, 536 refractory complex-partial status epilepticus, propofol treatment, vagal nerve stimulation by NCP system, 549 105 Deep brain stimulation Dysmyelination nystagmus induced by, in epilepsy, 1637 18q- deletion syndrome, autonomic seizures vs. syncope, 1039 Definitions, febrile seizures, 2 Dysplasia Demographics cortical, with ossification, 1489 antiepileptic drug retention rates, in epilepsy, 1592 clonazepam effects, in children with epilepsy, 308 Economics health care costs in epilepsy, 1020 cost of epilepsy, 342 health status in epilepsy, 85 health care in epilepsy, 1020 levetiracetam as add-on therapy, refractory partial seizures, 1179 trials in private clinical practice, 875 occipital lobe epilepsy, neuropsychological factors, 405 Edema patient-based assessment of NEWQOL, newly diagnosed epilepsy, vigabatrin-induced intramyelinic, 148 1119 Education remote memory, in epilepsy, 231 social factors of epilepsy, in Europe, 998 single seizures, impact on health status and health care utilization, Electrocardiography (ECG) 170 partial seizures in refractory epilepsy, 542 stigma of epilepsy in Europe, 98 Electrocorticography temporal lobe epilepsy, cerebellar atrophy, 1315 reactive post-resection spikes, 1463 Dendrites Electrodes and potassium channels, in hippocampal pyramidal neurons, 1072 cavernous sinus EEG, temporal lobe seizures, 1411 Dentate gyrus intracranial, after failed invasive monitoring, 571 calcium channel modulation by glutamate receptors, temporal lobe intracranial, complication of, 898 epilepsy, 1249 temporal depth, ictal spiking, 316 progenitor cell division, induction by limbic seizures, 10 Electroencephalography (EEG) Depression absence seizures, tonic-clonic activity, 391 and cognitive function, in epilepsy, 421 autosomal dominant nocturnal frontal lobe epilepsy, 52 postoperative, and preoperative emotional adjustment, temporal BCECTS (benign localization-related epilepsy in children), atypi- lobe epilepsy, 177 cal evolution, 380 Epilepsia, Vol. 41, No. 12, 2000

See more

The list of books you might like

Upgrade Premium
Most books are stored in the elastic cloud where traffic is expensive. For this reason, we have a limit on daily download.
DMCA & Copyright: Dear all, most of the website is community built, users are uploading hundred of books everyday, which makes really hard for us to identify copyrighted material, please contact us if you want any material removed.
Copyright @ PDFdrive.to, 2022 | We love our users